5.1.3.7 Abortion, Missed http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26382745&form=6&db=m Bleeding after dilatation and curettage: the efficacy of transcatheter uterine artery embolisation. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19361799&form=6&db=m Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. diagnostic usage,unassigned 3,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19804021&form=6&db=m Uterine artery embolization and future fertility potential. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20386442&form=6&db=m Impact of previous uterine artery embolization on fertility. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23701904&form=6&db=m Uterine artery embolization and its effect on fertility. unassigned - 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25018653&form=6&db=m Embolization of uterine fibroids from the point of view of the gynecologist: pros and cons. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26633901&form=6&db=m Uterine Fibroid Embolisation - Potential Impact on Fertility and Pregnancy Outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29052017&form=6&db=m Fertility after uterine artery embolization of fibroids: a systematic review. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,4 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32081542&form=6&db=m Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids. therapeutic application,unassigned 4,0 5.1.3.7 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32841756&form=6&db=m Nonextirpative Treatments for Uterine Myomas: Measuring Success. unassigned - 5.1.3.7 Abruptio Placentae http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24670673&form=6&db=m UTERINE ARTERY EMBOLIZATION FOR UTERINE ARTERIOVENOUS MALFORMATION IS ASSOCIATED WITH PLACENTAL ABNORMALITIES IN THE SUBSEQUENT PREGNANCY: TWO CASES REPORT. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Abruptio Placentae http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27589544&form=6&db=m Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. causal interaction,unassigned 2,0 5.1.3.7 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16414795&form=6&db=m The position of AIDS in Pakistan, UAE and Jordan. unassigned - 5.1.3.7 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23465260&form=6&db=m Intramural ectopic pregnancy: treatment using uterine artery embolization. causal interaction,therapeutic application,unassigned 2,3,0 5.1.3.7 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29698434&form=6&db=m Evaluation of a photographic food atlas as a tool for quantifying food portion size in the United Arab Emirates. therapeutic application,unassigned 2,0 5.1.3.7 Acromegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10831175&form=6&db=m Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,3,0 5.1.3.7 Acromegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32995046&form=6&db=m Clinical Presentation, Treatment, and Outcome of Acromegaly in the United Arab Emirates. diagnostic usage,ongoing research,unassigned 3,4,0 5.1.3.7 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15461981&form=6&db=m Acute renal failure after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15381909&form=6&db=m Uterine artery embolization of leiomyomas with trisacryl gelatin microspheres (TGM): pathologic features and comparison with polyvinyl alcohol emboli. causal interaction,therapeutic application,unassigned 1,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11953068&form=6&db=m [Uterine arterial embolization in the treatment of adenomyosis] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12411014&form=6&db=m [Investigation of the hemodynamic changes during uterine arterial embolization in the treatment of adenomyosis] causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12525461&form=6&db=m Incomplete vaginal expulsion of pyoadenomyoma with sepsis and focal bladder necrosis after uterine artery embolization for symptomatic adenomyosis: case report. diagnostic usage,therapeutic application,unassigned 3,2,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691595&form=6&db=m Uterine artery embolization for symptomatic uterine leiomyoma and adenomyosis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15958862&form=6&db=m Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16319152&form=6&db=m Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16498121&form=6&db=m MRI of adenomyosis: changes with uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17179361&form=6&db=m Long-term results of uterine artery embolization for symptomatic adenomyosis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17199918&form=6&db=m [Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17609441&form=6&db=m Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18280686&form=6&db=m Uterine artery embolisation for symptomatic adenomyosis-Mid-term results. causal interaction,ongoing research,therapeutic application,unassigned 4,3,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18843968&form=6&db=m [Intermediate and long term clinical effects of uterine arterial embolization with sodium alginate microspheres in treatment of diffuse adenomyosis] causal interaction,ongoing research,therapeutic application,unassigned 1,2,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19048334&form=6&db=m Spectrum of imaging findings on MRI and CT after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21570318&form=6&db=m Uterine artery embolization for the treatment of adenomyosis: a review. therapeutic application,unassigned 4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21717251&form=6&db=m Long-Term Follow-up of Uterine Artery Embolization for Symptomatic Adenomyosis. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,4,2 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21850565&form=6&db=m Uterine Artery Embolization to Treat Uterine Adenomyosis with or without Uterine Leiomyomata: Results of Symptom Control and Health-Related Quality of Life 40 Months after Treatment. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,2,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22161234&form=6&db=m [Change in health-related quality of life and change in clinical symptoms after uterine artery embolization in patients with symptomatic adenomyosis uteri - evaluation using a standardized questionnaire]. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22221154&form=6&db=m Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - An interim report on an Australian experience. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24657088&form=6&db=m The Effect of Uterine Artery Embolization on Premenstrual Symptoms in Patients with Symptomatic Fibroids or Adenomyosis. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26074028&form=6&db=m Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence. diagnostic usage,therapeutic application,unassigned 4,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26372352&form=6&db=m Uterine artery embolization for symptomatic fibroids in postmenopausal women. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,1,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26667403&form=6&db=m The effects of single-dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26868068&form=6&db=m The evaluation of uterine artery embolization as a nonsurgical treatment option for adenomyosis. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27806072&form=6&db=m Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,2 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28516272&form=6&db=m Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28807810&form=6&db=m Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29032946&form=6&db=m Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29128204&form=6&db=m Uterine artery embolization: A review of current concepts. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29344938&form=6&db=m A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: Results in 117 women. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,2,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29477623&form=6&db=m Uterine Artery Embolization for Pedunculated Subserosal Leiomyomas: Evidence of Safety and Efficacy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,4 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29496654&form=6&db=m Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Adenomyosis: Protocol for the Randomized QUESTA Trial. diagnostic usage,ongoing research,therapeutic application,unassigned 1,4,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30373724&form=6&db=m Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31544371&form=6&db=m Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32020527&form=6&db=m Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33548995&form=6&db=m The prognostic role of ovarian endometriosis in symptomatic adenomyosis patients underwent uterine artery embolization. ongoing research,unassigned 1,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33583017&form=6&db=m Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis. diagnostic usage,therapeutic application,unassigned 1,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33775917&form=6&db=m Successful pregnancy outcome in refractory adenomyosis treated with two sessions of uterine artery embolization: A case report and brief review. causal interaction,unassigned 3,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34147191&form=6&db=m Uterine Artery Embolization for Adenomyosis. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Adenomyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34194918&form=6&db=m Can uterine artery embolization be an alternative to plastic and reconstructive uterus operation by minimally invasive surgery? unassigned - 5.1.3.7 African Horse Sickness http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32303305&form=6&db=m African Horse Sickness Fever in Vaccinated Horses: Short Communication. unassigned - 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2182231&form=6&db=m Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria. diagnostic usage,unassigned 3,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3802503&form=6&db=m Laser immunonephelometry for routine quantification of urinary albumin excretion. causal interaction,unassigned 3,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7956637&form=6&db=m Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8173695&form=6&db=m Increased urinary C-peptide and albumin excretion in juvenile borderline hypertensives. causal interaction,unassigned 1,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8246767&form=6&db=m Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. diagnostic usage,unassigned 2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8420815&form=6&db=m Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,3 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8425659&form=6&db=m Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,1 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9539998&form=6&db=m The association between diabetic complications and exercise capacity in NIDDM patients. diagnostic usage,unassigned 1,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10410380&form=6&db=m Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10526743&form=6&db=m Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11004219&form=6&db=m Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. unassigned - 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12397040&form=6&db=m Genetic dissection of increased urinary albumin excretion in the munich wistar frömter rat. causal interaction,ongoing research,unassigned 1,1,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584270&form=6&db=m Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,4,1 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16208149&form=6&db=m The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17021266&form=6&db=m Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. causal interaction,ongoing research,therapeutic application,unassigned 4,2,3,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17921827&form=6&db=m Induction of C1q expression in glomerular endothelium in a rat model with arterial hypertension and albuminuria. ongoing research,unassigned 2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17953514&form=6&db=m Protective effect of female gender on the development of albuminuria in a polygenetic rat model is enhanced further by replacement of a major autosomal QTL. ongoing research,unassigned 2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20637965&form=6&db=m Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. unassigned - 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20733300&form=6&db=m Level of albuminuria and risk of stroke: systematic review and meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21441399&form=6&db=m Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) Study. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22231032&form=6&db=m Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? causal interaction,diagnostic usage,unassigned 4,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23340892&form=6&db=m Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24350298&form=6&db=m Levels of inflammatory cytokines in type 2 diabetes patients with different urinary albumin excretion rates and their correlation with clinical variables. unassigned - 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24464020&form=6&db=m The role of adiponectin in renal physiology and development of albuminuria. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26188433&form=6&db=m Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study. diagnostic usage,unassigned 1,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26726005&form=6&db=m Which Measurement of Blood Pressure Is More Associated With Albuminuria in Patients With Type 2 Diabetes: Central Blood Pressure or Peripheral Blood Pressure? diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26948447&form=6&db=m Bariatric surgery reduces urinary albumin excretion in diabetic nephropathy: a systematic review and meta-analysis. diagnostic usage,unassigned 4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27254313&form=6&db=m Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27965374&form=6&db=m Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study. causal interaction,diagnostic usage,unassigned 2,4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29894207&form=6&db=m Inverse correlation between serum adiponectin level and albuminuria in pregnancy-induced hypertension patients. causal interaction,unassigned 4,0 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31078666&form=6&db=m Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial. unassigned - 5.1.3.7 Albuminuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32980790&form=6&db=m Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 Alkaptonuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18945288&form=6&db=m R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,4,0 5.1.3.7 Amebiasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23666654&form=6&db=m Differential detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in fecal samples by nested PCR in the United Arab Emirates (UAE). diagnostic usage,unassigned 4,0 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8880043&form=6&db=m Anaemia among 6 year old children in the United Arab Emirates. unassigned - 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15573190&form=6&db=m Cultural and ethnic barriers in conducting research. Factors influencing menarche in the United Arab Emirates. diagnostic usage,unassigned 2,0 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18410711&form=6&db=m Anemia among female college students attending the University of Sharjah, UAE: prevalence and classification. causal interaction,diagnostic usage,ongoing research,unassigned 3,2,1,0 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23606864&form=6&db=m Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. unassigned - 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24099448&form=6&db=m Fibroid Infected With Escherichia Coli Requiring Surgical Removal Following Uterine Artery Embolization. causal interaction,therapeutic application,unassigned 2,3,0 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28951427&form=6&db=m An unexpected complication following uterine artery embolisation. therapeutic application,unassigned 1,0 5.1.3.7 Anemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34217488&form=6&db=m Enhanced myometrial vascularity: case presentation and review. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Anemia, Iron-Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23606864&form=6&db=m Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. unassigned - 5.1.3.7 Anemia, Sickle Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12461072&form=6&db=m Accuracy of the urinary albumin to creatinine ratio as a predictor of albuminuria in adults with sickle cell disease. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Anemia, Sickle Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16602448&form=6&db=m Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. diagnostic usage,unassigned 1,0 5.1.3.7 Anemia, Sickle Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20437613&form=6&db=m Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Aneurysm, False http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19416573&form=6&db=m Femoral artery puncture site pseudoaneurysm formation following uterine artery embolization for symptomatic fibroids: a case report. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Aneurysm, False http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32052234&form=6&db=m The efficacy of uterine artery embolization with gelatin sponge for retained products of conception with bleeding and future pregnancy outcomes. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Arthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28511684&form=6&db=m Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 Arthritis, Juvenile http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28511684&form=6&db=m Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 Arthritis, Rheumatoid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24261616&form=6&db=m Rheumatoid arthritis disease activity and vitamin D deficiency in an Asian resident population. causal interaction,ongoing research,unassigned 2,3,0 5.1.3.7 Arthritis, Rheumatoid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25315703&form=6&db=m Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study. therapeutic application,unassigned 1,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8175636&form=6&db=m Asthma and wheezing as the cause of school absence. causal interaction,unassigned 3,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10900696&form=6&db=m Asthma and respiratory symptoms among school children in United Arab Emirates. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19439923&form=6&db=m Prevalence and Risk Factors of Asthma among Adolescents and Their Parents in Al-Ain (United Arab Emirates). causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20484926&form=6&db=m Allergic rhinitis and asthma: a large cross-sectional study in the United Arab Emirates. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20981181&form=6&db=m Asthma insights and reality in the United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22340199&form=6&db=m Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29664734&form=6&db=m Potential causes of asthma in the United Arab Emirates: drawing insights from the Arabian Gulf. causal interaction,ongoing research,unassigned 2,3,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33436091&form=6&db=m A simulated patient study to evaluate community pharmacist assessment, management and advice giving to patients with asthma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33673280&form=6&db=m Assessment of Novel Inhaler Technique Reminder Labels in Image Format on the Correct Demonstration of Inhaler Technique Skills in Asthma: A Single-Blinded Randomized Controlled Trial. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34012484&form=6&db=m Demographic and clinical patterns of severe asthma in the Middle East. causal interaction,unassigned 4,0 5.1.3.7 Astigmatism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31134425&form=6&db=m Evaluation of biometry and corneal astigmatism in cataract surgery patients in Northern United Arab Emirates. therapeutic application,unassigned 4,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1413813&form=6&db=m Risk factors for atherosclerosis in female type II diabetic patients with incipient diabetic nephropathy. diagnostic usage,unassigned 2,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10027580&form=6&db=m Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11902818&form=6&db=m Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19390209&form=6&db=m Cardiorenal Risk Prevalence in Sickle Cell Hemoglobinopathy. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19417196&form=6&db=m Microalbuminuria and risk of venous thromboembolism. diagnostic usage,unassigned 2,0 5.1.3.7 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31205201&form=6&db=m Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130259&form=6&db=m Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. causal interaction,unassigned 4,0 5.1.3.7 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23470495&form=6&db=m Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. causal interaction,diagnostic usage,unassigned 2,4,0 5.1.3.7 Autoimmune Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30835520&form=6&db=m Uterine Artery Embolization in Patients With Autoimmune Disease: A Matched Case-Control Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Bacteremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33399491&form=6&db=m Sepsis following hysteroscopic myomectomy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,4,0 5.1.3.7 beta-Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15767753&form=6&db=m Molecular heterogeneity of beta-thalassemia in the United Arab Emirates. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Blastocystis Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31580985&form=6&db=m Molecular Subtyping of Blastocystis from Diverse Animals in the United Arab Emirates. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Brain Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32795357&form=6&db=m Epidemiology of brain tumors in the United Arab Emirates: a National Registry Cross-sectional Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,4,1 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10859003&form=6&db=m Increased urinary albumin excretion rate in breast cancer patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,4,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22126512&form=6&db=m A commentary on delayed presentation of breast cancer in singapore. unassigned - 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23110340&form=6&db=m Young women in the UAE have higher incidence of HER2 positive breast cancer. causal interaction,unassigned 4,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24083768&form=6&db=m Breast Self Examination Practice and Breast Cancer Risk Perception among Female University Students in Ajman. unassigned - 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29349136&form=6&db=m Breast cancer presentation delays among Arab and national women in the UAE: a qualitative study. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29777908&form=6&db=m Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29862141&form=6&db=m The Role of Diet and Lifestyle in Women with Breast Cancer: An Update Review of Related Research in the Middle East. ongoing research,unassigned 2,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30145548&form=6&db=m Breast Cancer Risk factor awareness and utilization of screening program: A cross-sectional study among women in the Northern Emirates. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30744593&form=6&db=m Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31244316&form=6&db=m Awareness about Breast Cancer and Breast Self-Examination among Female Students at the University of Sharjah: A Cross-Sectional Study. causal interaction,ongoing research,unassigned 3,2,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32132057&form=6&db=m Correlation of Insulin-like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32745951&form=6&db=m Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33218122&form=6&db=m Women's Breast Cancer Knowledge and Health Communication in the United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33754294&form=6&db=m Knowledge, Attitudes, and Practices Concerning Breast Cancer and Self Examination Among Females in UAE. ongoing research,unassigned 2,0 5.1.3.7 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33951102&form=6&db=m Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 5.1.3.7 Candidiasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24102778&form=6&db=m Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. diagnostic usage,ongoing research,unassigned 2,3,0 5.1.3.7 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11821609&form=6&db=m Squamous metaplasia of endometrium after uterine artery embolization for symptomatic leiomyomata. causal interaction,unassigned 4,0 5.1.3.7 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15190657&form=6&db=m Epidemiology of prostate cancer in United Arab Emirates. unassigned - 5.1.3.7 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23985381&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28156221&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14501709&form=6&db=m Prognostic significance of albuminuria in patients with renal cell cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Carcinoma, Squamous Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23985381&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Carcinoma, Squamous Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28156221&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8174446&form=6&db=m Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control. causal interaction,unassigned 4,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8630672&form=6&db=m Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: relevance to cardiovascular disease. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8862223&form=6&db=m Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9226225&form=6&db=m Elevated albumin excretion in nonmodulating essential hypertensive patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10212361&form=6&db=m Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. causal interaction,diagnostic usage,unassigned 3,3,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10817400&form=6&db=m Plasma concentrations of endothelial vasoactive substances in clinically healthy subjects. associations with urinary albumin excretion and ambulatory blood pressure. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12675640&form=6&db=m Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788356&form=6&db=m Childhood obesity in United Arab Emirates schoolchildren: a national study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16015000&form=6&db=m Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16860430&form=6&db=m Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16871239&form=6&db=m Time to abandon microalbuminuria? unassigned - 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17453140&form=6&db=m Low-grade albuminuria and cardiovascular risk : what is the evidence? causal interaction,unassigned 3,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18335264&form=6&db=m Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362254&form=6&db=m Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,4,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19371412&form=6&db=m Associations of cardiovascular risk factors in Al Ain- United Arab Emirates. diagnostic usage,unassigned 2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19473676&form=6&db=m [Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension] causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19644823&form=6&db=m [Renal dysfunction as a marker of cardiovascular risk]. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24464020&form=6&db=m The role of adiponectin in renal physiology and development of albuminuria. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24550221&form=6&db=m Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26734321&form=6&db=m Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction In Primary Percutaneous Intervention: Transformation using Robust Performance Improvement. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26758793&form=6&db=m Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27013911&form=6&db=m Evaluation and implementation of behavioral and educational tools that improves the patients' intentional and unintentional non-adherence to cardiovascular medications in family medicine clinics. ongoing research,unassigned 3,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27821100&form=6&db=m Exploratory study into the awareness of heart diseases among Emirati women (UAE) and their health seeking behaviour- a qualitative study. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30607775&form=6&db=m Association of neutrophil-to-lymphocyte ratio with early renal dysfunction and albuminuria among diabetic patients. causal interaction,diagnostic usage,unassigned 1,4,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32830071&form=6&db=m Pharmacists' experiences and views on providing screening services: An international comparison. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33520290&form=6&db=m Predictive Value of Creatinine-based Equations of Kidney Function in the Long-term Prognosis in United Arab Emirates Patients. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Cataract http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31134425&form=6&db=m Evaluation of biometry and corneal astigmatism in cataract surgery patients in Northern United Arab Emirates. therapeutic application,unassigned 4,0 5.1.3.7 Celiac Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30210717&form=6&db=m Occurrence of Hypothyroidism, Diabetes Mellitus, and Celiac Disease in Emirati Children with Down's Syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Cellulitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31637068&form=6&db=m Severe Presentation of Nontypeable Haemophilus influenzae (NTHi) Infection in a Previously Healthy Toddler. unassigned - 5.1.3.7 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16918820&form=6&db=m Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. causal interaction,diagnostic usage,unassigned 3,3,0 5.1.3.7 Chickenpox http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20187531&form=6&db=m Pattern of varicella and associated complications in children in Unite Arab Emirates: 5-year descriptive study. causal interaction,unassigned 4,0 5.1.3.7 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31998621&form=6&db=m Salmonella enterica and Theileria co-infection in dromedary camels (Camelus dromedarius) in UAE. unassigned - 5.1.3.7 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34234167&form=6&db=m Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response. causal interaction,ongoing research,unassigned 2,3,0 5.1.3.7 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34526633&form=6&db=m Publisher Correction: Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response. causal interaction,ongoing research,unassigned 1,3,0 5.1.3.7 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28950678&form=6&db=m Predictors of Colorectal Cancer Knowledge among Adults in the United Arab Emirates diagnostic usage,ongoing research,unassigned 3,2,0 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19260572&form=6&db=m Hepatitis E: a common cause of acute viral hepatitis. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20201174&form=6&db=m Chickenpox: presentation and complications in adults. ongoing research,unassigned 2,0 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20566529&form=6&db=m Global public health and the United Arab Emirates. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20701889&form=6&db=m Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23469200&form=6&db=m Deaths and medical visits attributable to environmental pollution in the United arab emirates. unassigned - 5.1.3.7 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33176049&form=6&db=m Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID-19) in hospitalized patients. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Confusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20537558&form=6&db=m Transdermal scopolamine patch with odansetron for the control of nausea after uterine artery embolization compared with odansetron alone: results of a randomized placebo-controlled trial. causal interaction,unassigned 4,0 5.1.3.7 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12769508&form=6&db=m Birth prevalence and pattern of osteochondrodysplasias in an inbred high risk population. therapeutic application,unassigned 4,0 5.1.3.7 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20437613&form=6&db=m Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20632007&form=6&db=m Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model. causal interaction,unassigned 1,0 5.1.3.7 Coronary Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10862638&form=6&db=m Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,1 5.1.3.7 Coronary Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12882845&form=6&db=m Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. diagnostic usage,unassigned 3,0 5.1.3.7 Coronary Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17875308&form=6&db=m Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study. causal interaction,diagnostic usage,unassigned 2,2,0 5.1.3.7 Coronary Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29181228&form=6&db=m Knowledge of warning signs, presenting symptoms and risk factors of coronary heart disease among the population of Dubai and Northern Emirates in UAE: a cross-sectional study. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Coronavirus Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29239118&form=6&db=m Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE. causal interaction,unassigned 1,0 5.1.3.7 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23290701&form=6&db=m Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. diagnostic usage,ongoing research,unassigned 3,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32171951&form=6&db=m Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data. diagnostic usage,unassigned 3,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32525467&form=6&db=m COVID-19 and acute ischemic stroke - A case series from Dubai, UAE. ongoing research,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32714122&form=6&db=m Shall Universities at the UAE Continue Distance Learning after the COVID-19 Pandemic? Revealing Students' Perspective. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32969340&form=6&db=m Investigating the Impact of COVID-19 on Psychological Health of University Students in UAE and their Attitudes Towards m-Mental Health Solutions: A Questionnaire Study. ongoing research,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33046991&form=6&db=m Negative Effects On Cancer Care Due To COVID-19 Implications: Observations From A Cancer Center In The UAE. ongoing research,therapeutic application,unassigned 3,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33082405&form=6&db=m Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East. ongoing research,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33130840&form=6&db=m Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients. A single-center experience. ongoing research,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33131867&form=6&db=m Detection and quantification of SARS-CoV-2 RNA in wastewater and treated effluents: Surveillance of COVID-19 epidemic in the United Arab Emirates. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33143926&form=6&db=m First confirmed detection of SARS-COV-2 in untreated municipal and aircraft wastewater in Dubai, UAE: The use of wastewater based epidemiology as an early warning tool to monitor the prevalence of COVID-19. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33176049&form=6&db=m Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID-19) in hospitalized patients. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33177898&form=6&db=m Increased Levels of Anxiety Among Medical and Non-Medical University Students During the COVID-19 Pandemic in the United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33284130&form=6&db=m Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33363185&form=6&db=m D-dimer, Troponin, and Urea Level at Presentation With COVID-19 can Predict ICU Admission: A Single Centered Study. diagnostic usage,therapeutic application,unassigned 4,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33488085&form=6&db=m Assessment of the Awareness, Perception, Attitudes, and Preparedness of Health-care Professionals Potentially Exposed to COVID-19 in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33506644&form=6&db=m Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33521243&form=6&db=m Climate effects on the COVID-19 outbreak: a comparative analysis between the UAE and Switzerland. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,3,1 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33563736&form=6&db=m Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33623526&form=6&db=m The dynamics of COVID-19 in the UAE based on fractional derivative modeling using Riesz wavelets simulation. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33670510&form=6&db=m Indirect Health Effects of COVID-19: Unhealthy Lifestyle Behaviors during the Lockdown in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33688401&form=6&db=m Impact of COVID-19 in the UAE Cardiovascular Services: A Statement from Emirates Cardiac and Emirates Intensive Care Societies. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33708993&form=6&db=m Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAE. ongoing research,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33718282&form=6&db=m Clinical and Laboratory Profile of Hospitalized Symptomatic COVID-19 Patients: Case Series Study From the First COVID-19 Center in the UAE. diagnostic usage,ongoing research,unassigned 1,4,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33729523&form=6&db=m The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33796033&form=6&db=m Impact of the Coronavirus Pandemic (COVID-19) Lockdown on Mental Health and Well-Being in the United Arab Emirates. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,4,3 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33816417&form=6&db=m Higher Temperatures, Higher Solar Radiation, and Less Humidity Is Associated With Poor Clinical and Laboratory Outcomes in COVID-19 Patients. diagnostic usage,ongoing research,unassigned 4,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33822950&form=6&db=m Erratum to: The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33828834&form=6&db=m Response to COVID-19 pandemic in the UAE: A public health perspective. therapeutic application,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33842686&form=6&db=m COVID-19 prediction using LSTM algorithm: GCC case study. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33941119&form=6&db=m The psychological impact of the COVID-19 pandemic on adults and children in the United Arab Emirates: a nationwide cross-sectional study. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33956910&form=6&db=m Readiness of physicians and medical students to cope with the COVID-19 pandemic in the UAE. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33979340&form=6&db=m COVID-19 knowledge, attitudes, and practices of United Arab Emirates medical and health sciences students: A cross sectional study. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33980523&form=6&db=m Forecasting the SARS COVID-19 pandemic and critical care resources threshold in the Gulf Cooperation Council (GCC) countries: population analysis of aggregate data. causal interaction,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34039299&form=6&db=m Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34069412&form=6&db=m COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents. causal interaction,diagnostic usage,unassigned 1,4,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34115768&form=6&db=m Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34118740&form=6&db=m Large variations in disease severity, death and ICU admission of 2993 patients infected with SARS-CoV-2: The potential impact of genetic vulnerability. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34179688&form=6&db=m Chest CT performance and features of COVID-19 in the region of Abu Dhabi, UAE: a single institute study. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34281501&form=6&db=m Impact of coronavirus 2019 on mental health and lifestyle adaptations of pregnant women in the United Arab Emirates: a cross-sectional study. causal interaction,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34291032&form=6&db=m Using Proper Mean Generation Intervals in Modeling of COVID-19. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34318774&form=6&db=m Prevalence of Burnout among Dental Students during COVID-19 Lockdown in UAE. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34350152&form=6&db=m Knowledge, Attitude, and Practices Toward SARS-COV-2 Infection in the United Arab Emirates Population: An Online Community-Based Cross-Sectional Survey. ongoing research,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34366960&form=6&db=m Levels of Trust in Information Sources as a Predictor of Protective Health Behaviors During COVID-19 Pandemic: A UAE Cross-Sectional Study. therapeutic application,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34401225&form=6&db=m Dynamics of a stochastic delay differential model for COVID-19 infection with asymptomatic infected and interacting people: Case study in the UAE. ongoing research,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34423037&form=6&db=m Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAE. unassigned - 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34427922&form=6&db=m Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34437554&form=6&db=m Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34461846&form=6&db=m Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID-19 in the UAE. therapeutic application,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34462158&form=6&db=m HLA repertoire of 115 UAE nationals infected with SARS-CoV-2. ongoing research,unassigned 1,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34462626&form=6&db=m Technology supported learning and pedagogy in times of crisis: the case of COVID-19 pandemic. ongoing research,unassigned 2,0 5.1.3.7 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34516548&form=6&db=m COVID-19 health awareness among the United Arab Emirates population. ongoing research,unassigned 4,0 5.1.3.7 Craniocerebral Trauma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22864712&form=6&db=m Epidemiology of head injury in the United Arab Emirates. causal interaction,unassigned 1,0 5.1.3.7 Craniocerebral Trauma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23441946&form=6&db=m Child and youth traffic-related injuries: use of a trauma registry to identify priorities for prevention in the United arab emirates. causal interaction,unassigned 1,0 5.1.3.7 Cushing Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718833&form=6&db=m Increased urinary albumin excretion in Cushing's syndrome: remission after correction of hypercortisolaemia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24652447&form=6&db=m On the life cycle and morphology of development stages of Paraspiralatus sakeri Gibbons et al., 2004 (Nematoda: Spiroidea, Spirocercidae), a heteroxenic stomach parasite of falcons. unassigned - 5.1.3.7 Deafness http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24194196&form=6&db=m Analysis of two Arab families reveals additional support for a DFNB2 nonsyndromic phenotype of MYO7A. unassigned - 5.1.3.7 Deafness http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29016196&form=6&db=m Prevalence of GJB2 Mutations in Affected Individuals from United Arab Emirates with Autosomal Recessive Nonsyndromic Hearing Loss. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Dental Caries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9511839&form=6&db=m Combination of low parental educational attainment and high parental income related to high caries experience in pre-school children in Abu Dhabi. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 5.1.3.7 Dental Caries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16759323&form=6&db=m Dental caries experience and use of dental services among preschool children in Ajman, UAE. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Dental Caries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24860920&form=6&db=m Epidemiology of dental caries in children in the United Arab Emirates. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Dental Caries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31873070&form=6&db=m Enamel defects and caries prevalence in preterm children aged 5-10 years in Dubai. unassigned - 5.1.3.7 Dental Caries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33874916&form=6&db=m Oral candidal carriage and its association with dental carious lesions in asymptomatic adults: a cross-sectional study from the UAE. causal interaction,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Dental Enamel Hypoplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30869585&form=6&db=m The Prevalence and Severity of Molar Incisor Hypomineralization and Molar Hypomineralization in Dubai, UAE. unassigned - 5.1.3.7 Dermatitis, Allergic Contact http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20617053&form=6&db=m Determination of para-phenylenediamine (PPD) in henna in the United Arab Emirates. causal interaction,unassigned 1,0 5.1.3.7 Dermatitis, Contact http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16929746&form=6&db=m Contact dermatitis in UAE. causal interaction,unassigned 4,0 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9264004&form=6&db=m Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12865039&form=6&db=m The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16015000&form=6&db=m Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20043039&form=6&db=m Physical activity and reported barriers to activity among type 2 diabetic patients in the United arab emirates. unassigned - 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22926941&form=6&db=m Podocyte specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a TEM stereometric analysis. therapeutic application,unassigned 1,0 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28107340&form=6&db=m Association of Diabetes Related Complications with Heart Rate Variability among a Diabetic Population in the UAE. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Diabetes Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28756345&form=6&db=m Gait alterations in the UAE population with and without diabetic complications using both traditional and entropy measures. unassigned - 5.1.3.7 Diabetes Insipidus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584270&form=6&db=m Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,4,1 5.1.3.7 Diabetes Insipidus, Neurogenic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18400823&form=6&db=m Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7675002&form=6&db=m [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8246767&form=6&db=m Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. diagnostic usage,unassigned 2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8873582&form=6&db=m Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10410380&form=6&db=m Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11369831&form=6&db=m Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11796177&form=6&db=m Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). causal interaction,unassigned 4,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12690921&form=6&db=m Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. causal interaction,unassigned 3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16374441&form=6&db=m Microalbuminuria in patients with previous myocardial infarction. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17069902&form=6&db=m Factors associated with microalbuminuria in resistant hypertension. diagnostic usage,unassigned 3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17880686&form=6&db=m The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18230135&form=6&db=m Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18259102&form=6&db=m Prevalence of increased albumin excretion rate in young saudi adults. causal interaction,unassigned 4,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18854761&form=6&db=m Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21483500&form=6&db=m Changes of some Health Indicators in Patients with Type 2 Diabetes: A Prospective Study in three Community Pharmacies in Sharjah, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24621466&form=6&db=m Home-measured heart rate is associated with albuminuria in patients with type 2 diabetes mellitus: a post-hoc analysis of a cross-sectional multicenter study. therapeutic application,unassigned 2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26435817&form=6&db=m Incidence of Type 2 Diabetes Mellitus among Emirati Residents in Ajman, United Arab Emirates. unassigned - 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26547504&form=6&db=m Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms. unassigned - 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28323045&form=6&db=m Vitamin D receptor gene polymorphisms among Emirati patients with type 2 diabetes mellitus. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28387897&form=6&db=m Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28878941&form=6&db=m Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. causal interaction,ongoing research,unassigned 4,3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29204365&form=6&db=m The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29717269&form=6&db=m Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE. diagnostic usage,unassigned 3,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30706787&form=6&db=m Growth of diabetes research in United Arab Emirates: current and future perspectives. causal interaction,unassigned 2,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31360316&form=6&db=m Lipid Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in Dubai: A Five-year Pattern. unassigned - 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31367640&form=6&db=m Frequency and Predisposing Factors for Drug-Induced Hypoglycemia in Patients with Type-2 Diabetes Mellitus. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32539861&form=6&db=m Oral health status and oral health-related quality of life among patients with type 2 diabetes mellitus in the United Arab Emirates: a matched case-control study. unassigned - 5.1.3.7 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32980790&form=6&db=m Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1568527&form=6&db=m Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2132407&form=6&db=m Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3201101&form=6&db=m Low-dose dopamine infusion, renal haemodynamics and urinary albumin excretion rate in insulin-dependent diabetics and in normal man. diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3519044&form=6&db=m High levels of growth hormone and human placental lactogen in pregnancy complicated by diabetes. causal interaction,unassigned 4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7675002&form=6&db=m [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8082528&form=6&db=m Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. causal interaction,unassigned 2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8137681&form=6&db=m The predictive value of microalbuminuria in IDDM. A five-year follow-up study. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8422765&form=6&db=m Decrease of glomerular hyperfiltration in short-term diabetic adolescents without microalbuminuria. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906979&form=6&db=m Hypertension in insulin-dependent diabetes. causal interaction,diagnostic usage,unassigned 2,2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9222653&form=6&db=m 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9407413&form=6&db=m High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus. therapeutic application,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9498638&form=6&db=m 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9509442&form=6&db=m Ambulatory blood pressures and autonomic nervous function in normoalbuminuric type I diabetic patients. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10862638&form=6&db=m Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,1 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11274272&form=6&db=m Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11796177&form=6&db=m Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). causal interaction,unassigned 4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12692749&form=6&db=m ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. causal interaction,ongoing research,therapeutic application,unassigned 4,3,4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15506069&form=6&db=m [Evolution of circadian blood pressure and urinary albumin excretion according to the type of diabetes over a 10-year period] causal interaction,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22856231&form=6&db=m Estimated glucose disposal rate in assessment of renal function in patients with type 1 diabetes. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25006750&form=6&db=m Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation - UAE Eastern Region experience. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26252955&form=6&db=m Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement. diagnostic usage,ongoing research,unassigned 3,4,0 5.1.3.7 Diabetes Mellitus, Type 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32596351&form=6&db=m The Epidemiology of Celiac Disease in the General Population and High-Risk Groups in Arab Countries: A Systematic Review. unassigned - 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1353802&form=6&db=m Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7675002&form=6&db=m [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8425659&form=6&db=m Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,1 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8544223&form=6&db=m Diabetes, obesity and hypertension in urban and rural people of bedouin origin in the United Arab Emirates. diagnostic usage,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8772592&form=6&db=m Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study. causal interaction,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8781291&form=6&db=m Lack of a relationship between urinary albumin excretion rate and insulin resistance in patients with non-insulin-dependent diabetes mellitus. ongoing research,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9387403&form=6&db=m Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9928752&form=6&db=m Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10410380&form=6&db=m Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10620206&form=6&db=m Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10866060&form=6&db=m Segregation analysis of urinary albumin excretion in families with type 2 diabetes. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11113686&form=6&db=m Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. therapeutic application,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11369831&form=6&db=m Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12060059&form=6&db=m Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes. diagnostic usage,ongoing research,unassigned 4,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12145184&form=6&db=m Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12500217&form=6&db=m Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12690921&form=6&db=m Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. causal interaction,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12830456&form=6&db=m Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15375799&form=6&db=m Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15506069&form=6&db=m [Evolution of circadian blood pressure and urinary albumin excretion according to the type of diabetes over a 10-year period] causal interaction,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15793194&form=6&db=m Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,2 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16186291&form=6&db=m Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. causal interaction,diagnostic usage,unassigned 4,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16479178&form=6&db=m Relationships between Heart Rate Variability and Urinary Albumin Excretion in Patients with Type 2 Diabetes. causal interaction,unassigned 4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17161769&form=6&db=m Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17699346&form=6&db=m Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18632180&form=6&db=m Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20059569&form=6&db=m Barriers and facilitators of weight management: perspectives of Arab women at risk for type 2 diabetes. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20413516&form=6&db=m A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients with Diabetic Nephropathy. therapeutic application,unassigned 4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21441399&form=6&db=m Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) Study. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21483500&form=6&db=m Changes of some Health Indicators in Patients with Type 2 Diabetes: A Prospective Study in three Community Pharmacies in Sharjah, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21788629&form=6&db=m Initial Angiotensin Receptor Blockade-Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22440125&form=6&db=m Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,4 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22924004&form=6&db=m Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention. unassigned - 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23047493&form=6&db=m Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23162680&form=6&db=m Type 2 diabetes care for patients in a tertiary care setting in UAE: a retrospective cohort study. ongoing research,therapeutic application,unassigned 1,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23551992&form=6&db=m Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24989952&form=6&db=m Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes. therapeutic application,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25371907&form=6&db=m Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study. diagnostic usage,ongoing research,unassigned 4,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25406966&form=6&db=m Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial. ongoing research,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25586553&form=6&db=m A novel approach to systematic random sampling in population surveys: Lessons from the United Arab Emirates National Diabetes Study (UAEDIAB). diagnostic usage,ongoing research,unassigned 4,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25892603&form=6&db=m Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial. unassigned - 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26252955&form=6&db=m Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement. diagnostic usage,ongoing research,unassigned 3,4,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26353820&form=6&db=m Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc). diagnostic usage,therapeutic application,unassigned 4,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26726005&form=6&db=m Which Measurement of Blood Pressure Is More Associated With Albuminuria in Patients With Type 2 Diabetes: Central Blood Pressure or Peripheral Blood Pressure? diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28323045&form=6&db=m Vitamin D receptor gene polymorphisms among Emirati patients with type 2 diabetes mellitus. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28387897&form=6&db=m Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28774945&form=6&db=m Arteriolar Hyalinosis Predicts Increase in Albuminuria and GFR Decline in Normo- and Microalbuminuric Japanese Patients With Type 2 Diabetes. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28878941&form=6&db=m Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. causal interaction,ongoing research,unassigned 4,3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29698434&form=6&db=m Evaluation of a photographic food atlas as a tool for quantifying food portion size in the United Arab Emirates. therapeutic application,unassigned 2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29717269&form=6&db=m Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE. diagnostic usage,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30860658&form=6&db=m Protein intake is not associated with progression of diabetic kidney disease in patients without macroalbuminuria. causal interaction,unassigned 1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32340285&form=6&db=m An Integrative Phenotype-Genotype Approach Using Phenotypic Characteristics from the UAE National Diabetes Study Identifies HSD17B12 as a Candidate Gene for Obesity and Type 2 Diabetes. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,3,1 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32539861&form=6&db=m Oral health status and oral health-related quality of life among patients with type 2 diabetes mellitus in the United Arab Emirates: a matched case-control study. unassigned - 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32980790&form=6&db=m Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32992327&form=6&db=m Metabolite signature of albuminuria involves amino acid pathways in 8,661 Finnish men without diabetes. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33334833&form=6&db=m Association between duration of residence and prevalence of type 2 diabetes among male South Asian expatriate workers in the United Arab Emirates: a cross-sectional study. causal interaction,ongoing research,unassigned 3,1,0 5.1.3.7 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33616911&form=6&db=m Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort. causal interaction,unassigned 3,0 5.1.3.7 Diabetes, Gestational http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33046000&form=6&db=m Burden, associated risk factors and adverse outcomes of gestational diabetes mellitus in twin pregnancies in Al Ain, UAE. diagnostic usage,unassigned 2,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1340938&form=6&db=m [Reversibility of early stage diabetic nephropathy] causal interaction,unassigned 3,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1568527&form=6&db=m Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1576356&form=6&db=m Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy. diagnostic usage,unassigned 4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3069935&form=6&db=m Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3535002&form=6&db=m Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8137681&form=6&db=m The predictive value of microalbuminuria in IDDM. A five-year follow-up study. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8425659&form=6&db=m Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,1 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8956306&form=6&db=m An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9051373&form=6&db=m Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9347246&form=6&db=m Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy. causal interaction,diagnostic usage,unassigned 4,3,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10862638&form=6&db=m Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,1 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11369830&form=6&db=m Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics. therapeutic application,unassigned 4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11586492&form=6&db=m Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12126767&form=6&db=m Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584270&form=6&db=m Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,4,1 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14669169&form=6&db=m A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16126118&form=6&db=m Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16373901&form=6&db=m Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16506273&form=6&db=m Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16860430&form=6&db=m Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22136913&form=6&db=m Association between serum fibroblast growth factor 21 and diabetic nephropathy. causal interaction,unassigned 3,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23340892&form=6&db=m Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26547504&form=6&db=m Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms. unassigned - 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30119978&form=6&db=m Cardiometabolic Risk Indicators for Kidney Disease in Mexican Patients with Type 2 Diabetes. diagnostic usage,unassigned 2,0 5.1.3.7 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30701803&form=6&db=m Normoalbuminuric chronic kidney disease in diabetes. unassigned - 5.1.3.7 Diabetic Neuropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11880927&form=6&db=m Electrophysiological changes in diabetic neuropathy: from subclinical alterations to disabling abnormalities. ongoing research,unassigned 2,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9498638&form=6&db=m 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10862638&form=6&db=m Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,1 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11194933&form=6&db=m Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17561963&form=6&db=m High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20627763&form=6&db=m [Albuminuria during the screening for diabetes in a semi-rural area (Kisantu City, DR Congo).] therapeutic application,unassigned 1,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21597231&form=6&db=m Flow-Mediated Dilation is Associated with Microalbuminuria Independent of Cardiovascular Risk Factors in Type 2 Diabetes. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30846231&form=6&db=m Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion. ongoing research,unassigned 1,0 5.1.3.7 Diffuse Cerebral Sclerosis of Schilder http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21305355&form=6&db=m Gender variability in presentation with Alpers' syndrome: a report of eight patients from the UAE. causal interaction,ongoing research,unassigned 4,2,0 5.1.3.7 Dirofilariasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18579995&form=6&db=m Ocular dirofilariasis in Dubai, UAE. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Disseminated Intravascular Coagulation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28251148&form=6&db=m Emergent Uterine Arterial Embolization Using N-Butyl Cyanoacrylate in Postpartum Hemorrhage with Disseminated Intravascular Coagulation. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Disseminated Intravascular Coagulation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31778209&form=6&db=m Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Diverticulum http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34249974&form=6&db=m Approaches in the Treatment of Cesarean Scar Pregnancy and Risk Factors for Intraoperative Hemorrhage: A Retrospective Study. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Down Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17159360&form=6&db=m Incidence of Down syndrome in Dubai, UAE. causal interaction,ongoing research,unassigned 3,1,0 5.1.3.7 Down Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28686324&form=6&db=m Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Down Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32596351&form=6&db=m The Epidemiology of Celiac Disease in the General Population and High-Risk Groups in Arab Countries: A Systematic Review. unassigned - 5.1.3.7 Drug-Related Side Effects and Adverse Reactions http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27330260&form=6&db=m Monitoring of adverse drug reactions in psychiatry outpatient department of a Secondary Care Hospital of Ras Al Khaimah, UAE. unassigned - 5.1.3.7 Dyslipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24944394&form=6&db=m Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Dyspnea http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3391894&form=6&db=m Ventilatory muscle recruitment during unsupported arm exercise in normal subjects. unassigned - 5.1.3.7 Dyspnea http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23290701&form=6&db=m Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. diagnostic usage,ongoing research,unassigned 3,1,0 5.1.3.7 Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19449063&form=6&db=m Fatal pulmonary embolus after uterine artery fibroid embolisation. causal interaction,unassigned 3,0 5.1.3.7 Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19637581&form=6&db=m [Effects of root-excision on trunk hydraulic traits and growth status of Ginkgo biloba] causal interaction,unassigned 3,0 5.1.3.7 Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25662846&form=6&db=m Characteristics of ultrasonic acoustic emissions from walnut branches during freeze-thaw-induced embolism formation. therapeutic application,unassigned 2,0 5.1.3.7 Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32672434&form=6&db=m Efficacy of different treatment of 134 cases of cesarean scar pregnancy. therapeutic application,unassigned 3,0 5.1.3.7 Endometrial Hyperplasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11821609&form=6&db=m Squamous metaplasia of endometrium after uterine artery embolization for symptomatic leiomyomata. causal interaction,unassigned 4,0 5.1.3.7 Endometritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32141044&form=6&db=m Intraoperative microvascular assessment with contrast-enhanced ultrasound (CEUS) during uterine artery embolisation (UAE): a case report and literature review. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Enzootic Bovine Leukosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32157519&form=6&db=m Serological evidence of enzootic bovine leukosis in the periurban dairy cattle production system of Al Ain, United Arab Emirates. unassigned - 5.1.3.7 Epilepsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9700835&form=6&db=m Public awareness and attitudes towards epilepsy in the United Arab Emirates. unassigned - 5.1.3.7 Epilepsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26078878&form=6&db=m Choice of Antiepileptic Drugs in Idiopathic Generalized Epilepsy: UAE Experience. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,2,2 5.1.3.7 Epilepsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26448591&form=6&db=m Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study. therapeutic application,unassigned 1,0 5.1.3.7 Epilepsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26576071&form=6&db=m Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Epilepsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27152460&form=6&db=m Societal problems that patients with epilepsy are facing in Sharjah, UAE. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,3,0 5.1.3.7 Epilepsy, Generalized http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26078878&form=6&db=m Choice of Antiepileptic Drugs in Idiopathic Generalized Epilepsy: UAE Experience. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,2,2 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1442855&form=6&db=m Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1528348&form=6&db=m Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2059393&form=6&db=m Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,3,2 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3602914&form=6&db=m Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy? unassigned - 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8471229&form=6&db=m Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. causal interaction,ongoing research,therapeutic application,unassigned 1,4,4,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906979&form=6&db=m Hypertension in insulin-dependent diabetes. causal interaction,diagnostic usage,unassigned 2,2,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9159655&form=6&db=m Correlates of abnormal urinary albumin excretion rates among primary care patients with essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9226225&form=6&db=m Elevated albumin excretion in nonmodulating essential hypertensive patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9377730&form=6&db=m Microalbuminuria in essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,3,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9786608&form=6&db=m An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. causal interaction,ongoing research,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9886903&form=6&db=m Circadian variation of urinary microalbumin excretion and ambulatory blood pressure in patients with essential hypertension. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10394569&form=6&db=m [Insertion/deletion polymorphism of the gene encoding for angiotensin-converting enzyme and microalbuminuria in essential arterial hypertension] causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,1 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10919124&form=6&db=m [Factors associated with changes in microalbuminuria during antihypertensive treatment] causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11131271&form=6&db=m Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11818701&form=6&db=m Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. causal interaction,therapeutic application,unassigned 4,2,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12532688&form=6&db=m [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril] causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,2 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15716710&form=6&db=m Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130268&form=6&db=m Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension. diagnostic usage,unassigned 3,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18854757&form=6&db=m Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension. causal interaction,unassigned 4,0 5.1.3.7 Essential Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25126874&form=6&db=m Clinical usefulness of a timed overnight (8 hours) Urine Albumin (microalbumin) excretion in monitor-ing treatment in benign essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Extensively Drug-Resistant Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20578495&form=6&db=m Tuberculosis and MDR-TB in the northern emirates of United Arab Emirates: a 5-year study. causal interaction,unassigned 3,0 5.1.3.7 Fetal Death http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27589544&form=6&db=m Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. causal interaction,unassigned 2,0 5.1.3.7 Fetal Death http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29949293&form=6&db=m Successful management of complete placenta previa after intrauterine fetal death in a second-trimester pregnancy by uterine artery embolization: case report and literature review. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19949190&form=6&db=m Fertility after uterine artery embolization: investigation using a sheep model. therapeutic application,unassigned 1,0 5.1.3.7 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32184677&form=6&db=m Obstetric Outcomes of Pregnancy After Uterine Artery Embolization. diagnostic usage,unassigned 3,0 5.1.3.7 Fetal Growth Retardation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34413380&form=6&db=m A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Fibroma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24505954&form=6&db=m [Uterine artery embolization--clinical problems]. therapeutic application,unassigned 1,0 5.1.3.7 Fluorosis, Dental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20187552&form=6&db=m National survey of the oral health of 12- and 15-year-old schoolchildren in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Fucosidosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23430803&form=6&db=m Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates : LSD in UAE. diagnostic usage,unassigned 1,0 5.1.3.7 Gallbladder Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27832205&form=6&db=m Gallstones: A Worldwide Multifaceted Disease and Its Correlations with Gallbladder Carcinoma. causal interaction,unassigned 3,0 5.1.3.7 Genetic Diseases, Inborn http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7897633&form=6&db=m The profile of major congenital abnormalities in the United Arab Emirates (UAE) population. causal interaction,unassigned 3,0 5.1.3.7 Genetic Diseases, Inborn http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20437613&form=6&db=m Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Genital Diseases, Female http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25510324&form=6&db=m Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review. diagnostic usage,unassigned 1,0 5.1.3.7 Genital Diseases, Female http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26775460&form=6&db=m Research on Ovary Blood Flow Before and After Uterine Artery Embolization with the Application of Color Doppler Blood Imaging. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,1,3 5.1.3.7 Gestational Trophoblastic Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28246515&form=6&db=m Efficacy of Prophylactic Uterine Artery Embolization before Obstetrical Procedures with High Risk for Massive Bleeding. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Gestational Trophoblastic Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32761723&form=6&db=m Conservative management of uterine artery pseudoaneurysm occurring during treatment of gestational trophoblastic disease: A case report. unassigned - 5.1.3.7 Glomerulosclerosis, Focal Segmental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540895&form=6&db=m Pattern of acute glomerulonephritis in adult population in Dubai: A single-center experience. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Glucose Intolerance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16374441&form=6&db=m Microalbuminuria in patients with previous myocardial infarction. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 glucose-6-phosphate dehydrogenase (nadp+) deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8860007&form=6&db=m Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Glucosephosphate Dehydrogenase Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8860007&form=6&db=m Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Glycogen Storage Disease Type II http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23430513&form=6&db=m The Changing Face of Infantile Pompe Disease: A Report of Five Patients from the UAE. causal interaction,unassigned 2,0 5.1.3.7 Glycogen Storage Disease Type II http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23430803&form=6&db=m Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates : LSD in UAE. diagnostic usage,unassigned 1,0 5.1.3.7 Graves Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27967219&form=6&db=m A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 5.1.3.7 Graves Ophthalmopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27967219&form=6&db=m A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 5.1.3.7 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29016196&form=6&db=m Prevalence of GJB2 Mutations in Affected Individuals from United Arab Emirates with Autosomal Recessive Nonsyndromic Hearing Loss. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32871514&form=6&db=m Mitochondrial mutations in non-syndromic hearing loss at UAE. causal interaction,unassigned 1,0 5.1.3.7 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33199029&form=6&db=m Clinical heterogeneity of the SLC26A4 gene in UAE patients with hearing loss and bioinformatics investigation of DFNB4/Pendred syndrome missense mutations. causal interaction,ongoing research,unassigned 1,2,0 5.1.3.7 Hearing Loss http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34201064&form=6&db=m Knowledge and Attitudes of Parents towards Childhood Hearing Loss and Pediatric Hearing Services in Sharjah, United Arab Emirates. diagnostic usage,unassigned 2,0 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11534041&form=6&db=m Prevalence of obesity among school children in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23606864&form=6&db=m Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. unassigned - 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27821100&form=6&db=m Exploratory study into the awareness of heart diseases among Emirati women (UAE) and their health seeking behaviour- a qualitative study. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28950842&form=6&db=m Exploratory study into awareness of heart disease and health care seeking behavior among Emirati women (UAE) - Cross sectional descriptive study. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Heart Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32134392&form=6&db=m Thanatogenomic Investigation of the Hydroxymethylome and Mitochondrial Genome of Cadaveric Cardiomyocytes: Proposal for a Proof-of-Concept Study. causal interaction,unassigned 3,0 5.1.3.7 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9227170&form=6&db=m Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27737597&form=6&db=m Coronary artery disease prevalence and outcome in patients hospitalized with acute heart failure: an observational report from seven Middle Eastern countries. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29788140&form=6&db=m Immune-unreactive urinary albumin as a predictor of cardiovascular events: the Hortega Study. unassigned - 5.1.3.7 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32095280&form=6&db=m Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East. ongoing research,unassigned 2,0 5.1.3.7 Hematuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16372748&form=6&db=m [Hematuria and acanthocyturia in patients with diabetes] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Hematuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540895&form=6&db=m Pattern of acute glomerulonephritis in adult population in Dubai: A single-center experience. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Hemoglobinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22074124&form=6&db=m Molecular basis of ?-thalassemia in the United Arab Emirates. ongoing research,unassigned 1,0 5.1.3.7 Hemorrhagic Fever, Crimean http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31602121&form=6&db=m Contact Tracing for an Imported Case of Crimean-Congo Hemorrhagic Fever - Experience from a Tertiary Care Center in Kerala, South India. unassigned - 5.1.3.7 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19260572&form=6&db=m Hepatitis E: a common cause of acute viral hepatitis. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16271396&form=6&db=m Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20633273&form=6&db=m Hepatitis B virus genotypes and precore and core mutants in UAE patients. causal interaction,ongoing research,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Hepatitis B http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22691239&form=6&db=m Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Hepatitis C http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21104026&form=6&db=m Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Hepatitis C http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22691239&form=6&db=m Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12062794&form=6&db=m Serological evidence for remarkably variable prevalence rates of Toxoplasma gondii in children of major residential areas in United Arab Emirates. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 5.1.3.7 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18444921&form=6&db=m Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. diagnostic usage,unassigned 4,0 5.1.3.7 Herpes Simplex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24982675&form=6&db=m Cervical Infection with Herpes simplex Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae among Symptomatic Women, Dubai, UAE: A Molecular Approach. ongoing research,therapeutic application,unassigned 2,3,0 5.1.3.7 Hip Dislocation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19618014&form=6&db=m Incidence of developmental dysplasia of the hip in Dubai. therapeutic application,unassigned 1,0 5.1.3.7 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33579057&form=6&db=m Prevalence of Syphilis and Human Immunodeficiency Virus in expatriates in Sharjah, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Hodgkin Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10644110&form=6&db=m Patient radiation dose associated with uterine artery embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,2 5.1.3.7 Hodgkin Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15857331&form=6&db=m Microalbuminuria in Hodgkin's disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,3,1 5.1.3.7 Homozygous Familial Hypercholesterolemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26311574&form=6&db=m Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. ongoing research,unassigned 1,0 5.1.3.7 Hydronephrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18574626&form=6&db=m Uterine artery embolization for ureteric obstruction secondary to fibroids. causal interaction,unassigned 3,0 5.1.3.7 Hypercholesterolemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8549734&form=6&db=m Relevance of cholesterol screening in the United Arab Emirates. A preliminary study. unassigned - 5.1.3.7 Hypercholesterolemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8869785&form=6&db=m Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 5.1.3.7 Hypercholesterolemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18259102&form=6&db=m Prevalence of increased albumin excretion rate in young saudi adults. causal interaction,unassigned 4,0 5.1.3.7 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9279479&form=6&db=m Effect of an alpha-glucosidase inhibitor on glomerular basement membrane anionic sites in streptozotocin induced mildly diabetic rats. unassigned - 5.1.3.7 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10334317&form=6&db=m Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. diagnostic usage,unassigned 1,0 5.1.3.7 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15059368&form=6&db=m [A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects] causal interaction,unassigned 3,0 5.1.3.7 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28042215&form=6&db=m Urine Albumin Excretion as a Marker of Acute Glycemic Changes in Isolated Postprandial Hyperglycemia. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,1,0 5.1.3.7 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32252655&form=6&db=m The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II. causal interaction,ongoing research,unassigned 1,1,0 5.1.3.7 Hyperinsulinism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10821335&form=6&db=m Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Hyperinsulinism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12745194&form=6&db=m Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Hyperinsulinism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19217093&form=6&db=m Predictors of urinary albumin excretion in women with polycystic ovary syndrome. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Hyperlipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31462957&form=6&db=m Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab Emirates. diagnostic usage,unassigned 3,0 5.1.3.7 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7559261&form=6&db=m Pet ownership in the UAE: its effect on allergy and respiratory symptoms. causal interaction,unassigned 2,0 5.1.3.7 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675621&form=6&db=m Safety and utility of uterine artery embolization with CO2 and a gadolinium-based contrast medium. therapeutic application,unassigned 4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1336463&form=6&db=m A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. ongoing research,therapeutic application,unassigned 4,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1442855&form=6&db=m Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7811439&form=6&db=m Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitus. causal interaction,unassigned 1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8173695&form=6&db=m Increased urinary C-peptide and albumin excretion in juvenile borderline hypertensives. causal interaction,unassigned 1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8733038&form=6&db=m Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. causal interaction,unassigned 2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8772592&form=6&db=m Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8879339&form=6&db=m Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension. therapeutic application,unassigned 2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906979&form=6&db=m Hypertension in insulin-dependent diabetes. causal interaction,diagnostic usage,unassigned 2,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9021431&form=6&db=m Clinical epidemiology of acute myocardial infarction in Sharjah, United Arab Emirates. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9159655&form=6&db=m Correlates of abnormal urinary albumin excretion rates among primary care patients with essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9227170&form=6&db=m Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9288546&form=6&db=m Increased prevalence of elevated urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9397252&form=6&db=m Association study between the ANF gene and hypertension in a Gulf Arab population. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9595780&form=6&db=m Microalbuminuria in essential hypertensives in treatment for hypertension. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9699090&form=6&db=m Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9786608&form=6&db=m An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. causal interaction,ongoing research,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10349195&form=6&db=m Microangiopathic complications in type 1 diabetes mellitus: differences in severity when isolated or associated with autoimmune polyendocrinopathies. causal interaction,diagnostic usage,unassigned 4,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10620206&form=6&db=m Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10821335&form=6&db=m Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10862638&form=6&db=m Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,1 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10872564&form=6&db=m Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11212976&form=6&db=m Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12397040&form=6&db=m Genetic dissection of increased urinary albumin excretion in the munich wistar frömter rat. causal interaction,ongoing research,unassigned 1,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12532688&form=6&db=m [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril] causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,2 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12733703&form=6&db=m Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1. causal interaction,ongoing research,unassigned 1,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12745194&form=6&db=m Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12799471&form=6&db=m Early onset albuminuria in Dahl rats is a polygenetic trait that is independent from salt loading. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16005369&form=6&db=m Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16015000&form=6&db=m Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16434504&form=6&db=m Urinary albumin excretion as a predictor of the development of hypertension in the general population. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16753071&form=6&db=m Under- treatment and under diagnosis of hypertension: a serious problem in the United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16860430&form=6&db=m Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17331548&form=6&db=m Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17333815&form=6&db=m Risk factors for hypertension in UAE. diagnostic usage,unassigned 4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17561963&form=6&db=m High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17702622&form=6&db=m Microalbuminuria and urinary albumin excretion: French clinical practice guidelines. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17919641&form=6&db=m [Microalbuminuria and urinary albumin excretion: clinical practice guidelines.] diagnostic usage,unassigned 4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17921827&form=6&db=m Induction of C1q expression in glomerular endothelium in a rat model with arterial hypertension and albuminuria. ongoing research,unassigned 2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17927826&form=6&db=m Prevalence of risk factors for diabetic foot complications. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18084117&form=6&db=m Investigation of microalbuminuria in nondiabetic, normotensive obese women. diagnostic usage,ongoing research,unassigned 2,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18087546&form=6&db=m [Association of microalbuminuria and von Willebrand factor with metabolic syndrome in hypertensive patients] causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18212449&form=6&db=m Hypertension in UAE Citizens - Preliminary Results of a Prospective Study. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18259102&form=6&db=m Prevalence of increased albumin excretion rate in young saudi adults. causal interaction,unassigned 4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18558566&form=6&db=m [Microalbuminuria and urinary albumin excretion: French guidelines] causal interaction,diagnostic usage,unassigned 3,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19217093&form=6&db=m Predictors of urinary albumin excretion in women with polycystic ovary syndrome. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19242728&form=6&db=m Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19421225&form=6&db=m Urinary albumin excretion is associated with true resistant hypertension. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19590230&form=6&db=m Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study. causal interaction,unassigned 2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20001457&form=6&db=m Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker. ongoing research,therapeutic application,unassigned 4,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20546144&form=6&db=m The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20627763&form=6&db=m [Albuminuria during the screening for diabetes in a semi-rural area (Kisantu City, DR Congo).] therapeutic application,unassigned 1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20668471&form=6&db=m Risk factors associated with urinary albumin excretion in African Americans. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21411384&form=6&db=m Microvascular complications and risk factors in patients with type 2 diabetes. causal interaction,diagnostic usage,unassigned 1,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21796123&form=6&db=m Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22170010&form=6&db=m Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22176929&form=6&db=m [Determination of urinary albumin excretion in arterial hypertension.] ongoing research,unassigned 2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277919&form=6&db=m Relationship between inflammation and microalbuminuria in prehypertension. causal interaction,unassigned 4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22440125&form=6&db=m Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,4 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22711274&form=6&db=m Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23105984&form=6&db=m Investigate the Role of Glutathione S Transferase (GST) Polymorphism in Development of Hypertension in UAE Population. ongoing research,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23113084&form=6&db=m The Use of Obesity Indicators for the Prediction of Hypertension Risk among Youth in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23459407&form=6&db=m Reduction in Morning Blood Pressure Is a Key Factor for Ameliorating Urinary Albumin Excretion in Patients With Morning Hypertension Irrespective of Treatment Regimen. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,3 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23606864&form=6&db=m Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. unassigned - 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24646879&form=6&db=m Blood Pressure Control Is Similar in Treated Hypertensive Patients With Optimal or With High-Normal Albuminuria. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25126874&form=6&db=m Clinical usefulness of a timed overnight (8 hours) Urine Albumin (microalbumin) excretion in monitor-ing treatment in benign essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25586553&form=6&db=m A novel approach to systematic random sampling in population surveys: Lessons from the United Arab Emirates National Diabetes Study (UAEDIAB). diagnostic usage,ongoing research,unassigned 4,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25885030&form=6&db=m Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates--a cross-sectional study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25948543&form=6&db=m Hypertension prevalence, awareness, treatment, and control, in male South Asian immigrants in the United Arab Emirates: a cross-sectional study. causal interaction,ongoing research,unassigned 2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27254313&form=6&db=m Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27643308&form=6&db=m LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. causal interaction,unassigned 1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28933781&form=6&db=m Relationship between subtle urinary albumin excretion and risk of incident hypertension: modification by glomerular filtration rate. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,2 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30967435&form=6&db=m Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,1,1 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31142962&form=6&db=m Urinary Albumin Excretion, Estimated Glomerular Filtration Rate, and Prevalence of Microalbuminuria in Obese Nondiabetic and Nonhypertensive Adults: A Cross-Sectional Study. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31592445&form=6&db=m Prevalence of diabetes and cardio-metabolic risk factors in young men in the United Arab Emirates: A cross-sectional national survey. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32252655&form=6&db=m The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II. causal interaction,ongoing research,unassigned 1,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33486986&form=6&db=m Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33616911&form=6&db=m Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort. causal interaction,unassigned 3,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33936937&form=6&db=m Application of the American College of Cardiology (ACC/AHA) 2017 Guideline for the Management of Hypertension in Adults and Comparison with the 2014 Eighth Joint National Committee Guideline. causal interaction,unassigned 1,0 5.1.3.7 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34261952&form=6&db=m Utility of urinary albumin excretion as an index for stratifying the residual cardiovascular risk in patients undergoing antihypertensive agents treatment. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Hypertriglyceridemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8869785&form=6&db=m Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 5.1.3.7 Hypertriglyceridemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12745194&form=6&db=m Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Hypertriglyceridemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23276621&form=6&db=m High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. causal interaction,unassigned 4,0 5.1.3.7 Hypertrophy, Left Ventricular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Hypertrophy, Left Ventricular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12690921&form=6&db=m Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. causal interaction,unassigned 3,0 5.1.3.7 Hypertrophy, Left Ventricular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130259&form=6&db=m Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. causal interaction,unassigned 4,0 5.1.3.7 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32568122&form=6&db=m A review of gestational diabetes mellitus management, risk factors, maternal and neonatal outcomes in two major maternity hospitals in the United Arab Emirates: A report from Dubai. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Hypotension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25189444&form=6&db=m New Injury Severity Score is a better predictor of mortality for blunt trauma patients than the Injury Severity Score. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Hypothyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30210717&form=6&db=m Occurrence of Hypothyroidism, Diabetes Mellitus, and Celiac Disease in Emirati Children with Down's Syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Inappropriate ADH Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18400823&form=6&db=m Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12062794&form=6&db=m Serological evidence for remarkably variable prevalence rates of Toxoplasma gondii in children of major residential areas in United Arab Emirates. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12475539&form=6&db=m Review of readmissions due to complications from uterine fibroid embolization. causal interaction,unassigned 3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12524075&form=6&db=m Serious complications of uterine artery embolization for conservative treatment of fibroids. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12934546&form=6&db=m [Uterine artery embolization for leiomyoma: complications and effects on fertility] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14514150&form=6&db=m Urinary albumin excretion and its relationship to C-reactive protein and proinflammatory cytokines in patients with cancer and febrile neutropenia. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14748076&form=6&db=m Detection and genotyping of TT virus in healthy and subjects with HBV or HCV in different populations in the United Arab Emirates. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,1 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15028817&form=6&db=m Pyosalpinx developing from a preexisting hydrosalpinx after uterine artery embolization. unassigned - 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15590799&form=6&db=m Risk of intrauterine infectious complications after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15827212&form=6&db=m Serologic surveillance for selected viral agents in captive and free-ranging populations of Arabian oryx (Oryx leucoryx) from Saudi Arabia and the United Arab Emirates. diagnostic usage,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17177296&form=6&db=m Genetic relationship of Torque Teno virus (TTV) between humans and camels in United Arab Emirates (UAE). causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18430385&form=6&db=m Septic uterus after uterine artery embolization for uterine myomas triggered by endometrial biopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19048334&form=6&db=m Spectrum of imaging findings on MRI and CT after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20461130&form=6&db=m Susceptibility Pattern and Epidemiology of Mycobacterium tuberculosis in United Emirati Hospital. causal interaction,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20566529&form=6&db=m Global public health and the United Arab Emirates. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20633273&form=6&db=m Hepatitis B virus genotypes and precore and core mutants in UAE patients. causal interaction,ongoing research,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23047493&form=6&db=m Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23845307&form=6&db=m A xenodiagnostic method using Musca domestica for the diagnosis of gastric habronemosis and examining the anthelmintic efficacy of moxidectin. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24102778&form=6&db=m Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. diagnostic usage,ongoing research,unassigned 2,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24505954&form=6&db=m [Uterine artery embolization--clinical problems]. therapeutic application,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24982675&form=6&db=m Cervical Infection with Herpes simplex Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae among Symptomatic Women, Dubai, UAE: A Molecular Approach. ongoing research,therapeutic application,unassigned 2,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25706932&form=6&db=m CRISPR-cas Subtype I-Fb in Acinetobacter baumannii: Evolution and Utilization for Strain Subtyping. therapeutic application,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26124673&form=6&db=m Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26762798&form=6&db=m Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28807810&form=6&db=m Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29998027&form=6&db=m Uterine Necrosis after Uterine Artery Embolization for Symptomatic Fibroids. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31000491&form=6&db=m The emerging pathogen Candida auris: A focus on the Middle-Eastern countries. therapeutic application,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31602121&form=6&db=m Contact Tracing for an Imported Case of Crimean-Congo Hemorrhagic Fever - Experience from a Tertiary Care Center in Kerala, South India. unassigned - 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31637068&form=6&db=m Severe Presentation of Nontypeable Haemophilus influenzae (NTHi) Infection in a Previously Healthy Toddler. unassigned - 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32181148&form=6&db=m Pyomyoma after uterine artery embolization: A case report. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32415247&form=6&db=m Obesity and Diabetes in an Arab population: Role of Adenovirus 36 Infection. causal interaction,unassigned 4,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32873300&form=6&db=m Immune response of horses to inactivated African horse sickness vaccines. unassigned - 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33011979&form=6&db=m Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection. unassigned - 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33256696&form=6&db=m Prevalence, virulence and antifungal activity of C. albicans isolated from infected root canals. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33432436&form=6&db=m Seroprevalence of Coxiella burnetii in a dairy cattle herd from the Al Ain region, United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33541590&form=6&db=m Uterine Myomas: Extravascular Treatment. causal interaction,diagnostic usage,unassigned 3,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33980523&form=6&db=m Forecasting the SARS COVID-19 pandemic and critical care resources threshold in the Gulf Cooperation Council (GCC) countries: population analysis of aggregate data. causal interaction,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34179688&form=6&db=m Chest CT performance and features of COVID-19 in the region of Abu Dhabi, UAE: a single institute study. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34215203&form=6&db=m Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34401225&form=6&db=m Dynamics of a stochastic delay differential model for COVID-19 infection with asymptomatic infected and interacting people: Case study in the UAE. ongoing research,unassigned 1,0 5.1.3.7 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34422542&form=6&db=m Forecasting Covid-19: SARMA-ARCH approach. ongoing research,unassigned 1,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12934546&form=6&db=m [Uterine artery embolization for leiomyoma: complications and effects on fertility] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15066481&form=6&db=m Retained calcified fibroid fragments after uterine artery embolization for fibroids. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16187443&form=6&db=m [Embolization of uterine arteries during myoma treatment from the patient's point of view] diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20101374&form=6&db=m [Collagen histomorphometric evaluation in uterin tissue samples before and after treatment of uterine fibroids with arterial embolization] diagnostic usage,ongoing research,unassigned 2,3,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22413857&form=6&db=m Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25018653&form=6&db=m Embolization of uterine fibroids from the point of view of the gynecologist: pros and cons. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27966042&form=6&db=m Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30538584&form=6&db=m Successful pregnancy after uterine artery embolization for uterine arterovenous malformation: a rare case report. unassigned - 5.1.3.7 Infertility http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31811462&form=6&db=m Uterine artery embolization for postpartum and postabortion hemorrhage: a retrospective analysis of complications, subsequent fertility and pregnancy outcomes. diagnostic usage,therapeutic application,unassigned 3,3,0 5.1.3.7 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31304223&form=6&db=m Knowledge, attitudes, and practice of healthcare workers toward influenza vaccination at Al Jalila Children's Specialty Hospital (AJCH), Dubai, UAE. therapeutic application,unassigned 1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7675002&form=6&db=m [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8246767&form=6&db=m Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. diagnostic usage,unassigned 2,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8781291&form=6&db=m Lack of a relationship between urinary albumin excretion rate and insulin resistance in patients with non-insulin-dependent diabetes mellitus. ongoing research,unassigned 3,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10480508&form=6&db=m Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. diagnostic usage,unassigned 4,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10526743&form=6&db=m Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10585306&form=6&db=m Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. diagnostic usage,unassigned 1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11102622&form=6&db=m Association of Acanthosis nigricans with risk of diabetes mellitus and hormonal disturbances in females. causal interaction,unassigned 4,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11684373&form=6&db=m Association of acanthosis nigricans with risk of diabetes mellitus, and hormonal disturbances in arabian females: case-control study. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15581333&form=6&db=m Hypertension and microalbuminuria: the new detrimental duo. causal interaction,unassigned 1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15793194&form=6&db=m Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,2 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16179893&form=6&db=m Microalbuminuria and hypertension. causal interaction,unassigned 3,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18091752&form=6&db=m Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18854761&form=6&db=m Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19242728&form=6&db=m Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20668471&form=6&db=m Risk factors associated with urinary albumin excretion in African Americans. unassigned - 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22856231&form=6&db=m Estimated glucose disposal rate in assessment of renal function in patients with type 1 diabetes. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23278488&form=6&db=m Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? diagnostic usage,unassigned 1,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23390836&form=6&db=m The metabolic syndrome is associated with high-normal urinary albumin excretion and retinopathy in normoalbuminuric type 1 diabetic patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30217931&form=6&db=m Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose or Impaired Glucose Tolerance. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 5.1.3.7 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32992327&form=6&db=m Metabolite signature of albuminuria involves amino acid pathways in 8,661 Finnish men without diabetes. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Intestinal Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31202907&form=6&db=m Prevalence and factors associated with infectious intestinal diseases in Ras Al Khaimah, United Arab Emirates, 2017: A population-based cross-sectional study. causal interaction,unassigned 2,0 5.1.3.7 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32525467&form=6&db=m COVID-19 and acute ischemic stroke - A case series from Dubai, UAE. ongoing research,unassigned 1,0 5.1.3.7 Kidney Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7675002&form=6&db=m [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Kidney Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29979643&form=6&db=m Provision of renal care for patients with end stage kidney disease in persistent vegetative state, in United Arab Emirates: a national survey of renal physicians. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Kidney Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259661&form=6&db=m Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes. diagnostic usage,unassigned 1,0 5.1.3.7 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584270&form=6&db=m Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,4,1 5.1.3.7 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16372748&form=6&db=m [Hematuria and acanthocyturia in patients with diabetes] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17949457&form=6&db=m Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients. ongoing research,therapeutic application,unassigned 3,1,0 5.1.3.7 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33560052&form=6&db=m Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Latent Autoimmune Diabetes in Adults http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26252955&form=6&db=m Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement. diagnostic usage,ongoing research,unassigned 3,4,0 5.1.3.7 Latent Infection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15608476&form=6&db=m Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 5.1.3.7 Leg Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2133017&form=6&db=m Microalbuminuria in sickle cell disease. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10319310&form=6&db=m Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10644110&form=6&db=m Patient radiation dose associated with uterine artery embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10868607&form=6&db=m Uterine artery embolization: a minimally invasive technique for the treatment of uterine fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11060372&form=6&db=m Anastomoses of the ovarian and uterine arteries: a potential pitfall and cause of failure of uterine embolization. ongoing research,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11259954&form=6&db=m Uterine artery embolization of symptomatic uterine fibroida . Initial success and short-term results. diagnostic usage,ongoing research,unassigned 4,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11287530&form=6&db=m Fibroid calcification after uterine artery embolization: ultrasonographic appearance and pathology. diagnostic usage,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11435540&form=6&db=m Utility of nonselective abdominal aortography in demonstrating ovarian artery collaterals in patients undergoing uterine artery embolization for fibroids. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11725729&form=6&db=m Women's decision-making determinants in choosing uterine artery embolization for symptomatic fibroids. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11818601&form=6&db=m Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12119326&form=6&db=m Magnetic resonance imaging outcome after uterine artery embolization for leiomyomata with use of tris-acryl gelatin microspheres. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12142860&form=6&db=m Time course of pain after uterine artery embolization for fibroid disease. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12195604&form=6&db=m Uterine artery embolization for the treatment of fibroids. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12376924&form=6&db=m Uterine leiomyoma after embolization by means of gelatin sponge particles alone: report of a case with histopathologic features. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12397123&form=6&db=m Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. ongoing research,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12449362&form=6&db=m Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,3,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12474325&form=6&db=m [Embolization of uterine fibroids] causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12501095&form=6&db=m Vesicouterine fistula after uterine artery embolization: a case report. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12524073&form=6&db=m The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12524074&form=6&db=m The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12524075&form=6&db=m Serious complications of uterine artery embolization for conservative treatment of fibroids. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12563136&form=6&db=m Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment--a prospective, randomized, and controlled clinical trial. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12934546&form=6&db=m [Uterine artery embolization for leiomyoma: complications and effects on fertility] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14504762&form=6&db=m [Role of magnetic resonance imaging (MRI) in establishing the indication for, planning, and following up uterine artery embolization (UAE) for treating symptomatic leiomyomas of the uterus] causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14521257&form=6&db=m Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14528437&form=6&db=m Transvaginal sonographic appearance of thrombosed uterine arteries after uterine artery embolization: the "white snake" sign. ongoing research,therapeutic application,unassigned 2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14551270&form=6&db=m Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14563603&form=6&db=m [Uterine fibroids embolization: results about 454 cases] diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14605104&form=6&db=m Leiomyoma recurrence after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14661496&form=6&db=m [Uterine leiomyoma embolization: Role of power Doppler ultrasonography] diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14691595&form=6&db=m Uterine artery embolization for symptomatic uterine leiomyoma and adenomyosis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14733778&form=6&db=m Superselective uterine arterial embolization with pingyangmycin-lipiodol emulsion for management of symptomatic uterine leiomyoma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14971005&form=6&db=m Contrast-enhanced sonography during uterine artery embolization for the treatment of leiomyomas. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15066463&form=6&db=m Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15066481&form=6&db=m Retained calcified fibroid fragments after uterine artery embolization for fibroids. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15101248&form=6&db=m [Embolization of uterine arteries yields good results in symptomatic myoma] causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15168005&form=6&db=m Pelvic organ prolapse after uterine artery embolization for uterine myoma. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15198761&form=6&db=m Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume. ongoing research,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15284774&form=6&db=m Patient satisfaction and disease specific quality of life after uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15297583&form=6&db=m Recovery after uterine artery embolization for leiomyomas: a detailed analysis of its duration and severity. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15381909&form=6&db=m Uterine artery embolization of leiomyomas with trisacryl gelatin microspheres (TGM): pathologic features and comparison with polyvinyl alcohol emboli. causal interaction,therapeutic application,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15461981&form=6&db=m Acute renal failure after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15590809&form=6&db=m Late leiomyoma expulsion after uterine artery embolization. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15617462&form=6&db=m Team approach with gynecologists taking the lead role in selecting patients for uterine artery embolization. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15642302&form=6&db=m Comparison of particle penetration with non-spherical polyvinyl alcohol versus trisacryl gelatin microspheres in women undergoing premyomectomy uterine artery embolization. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15726223&form=6&db=m Uterine artery embolisation for symptomatic fibroids in a tertiary hospital in Singapore. causal interaction,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15729564&form=6&db=m Uterine restoration after repeated sloughing of fibroids or vaginal expulsion following uterine artery embolization. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15797303&form=6&db=m Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15821634&form=6&db=m Uterine artery embolization for fibroids. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15950659&form=6&db=m Abdominal myomectomy after failed uterine artery embolization. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15958862&form=6&db=m Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16105928&form=6&db=m Primary failure of uterine artery embolization: use of magnetic resonance imaging to select patients for repeated embolization. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16129548&form=6&db=m Treatment of uterine fibroids by embolization--advantages, disadvantages, and pitfalls. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16160102&form=6&db=m Uterine artery embolization for leiomyomas: pre- and postprocedural evaluation with US. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16187443&form=6&db=m [Embolization of uterine arteries during myoma treatment from the patient's point of view] diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16195836&form=6&db=m Mid-term clinical results and patient satisfaction after uterine artery embolization in women with symptomatic uterine fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,2,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16227486&form=6&db=m Imaging manifestations of complications associated with uterine artery embolization. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16287010&form=6&db=m Improving quality of care for patients undergoing arterial embolization for uterine fibroids: case report and review. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16319152&form=6&db=m Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16406733&form=6&db=m [Uterine embolization for submucous fibroid: a bad alternative to surgery?] therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16437515&form=6&db=m Uterine artery embolization for symptomatic uterine fibroids. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16517773&form=6&db=m Limited Uterine Artery Embolization for Leiomyomas with Tris-Acryl Gelatin Microspheres: 1-Year Follow-up. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16567671&form=6&db=m Uterine Artery Embolization in the Treatment of Symptomatic Uterine Fibroid Tumors (EMMY Trial): Periprocedural Results and Complications. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16877371&form=6&db=m Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16907697&form=6&db=m Uterine artery embolization as a treatment for symptomatic uterine fibroids: a review of literature and case report. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16908679&form=6&db=m Uterine Fibroids: Contrast-enhanced MR Angiography to Predict Ovarian Artery Supply--Initial Experience. causal interaction,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16923975&form=6&db=m A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17083970&form=6&db=m Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17135018&form=6&db=m Role of magnetic resonance imaging in patient selection for uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17179361&form=6&db=m Long-term results of uterine artery embolization for symptomatic adenomyosis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17185691&form=6&db=m Treatment of intrauterine and large pedunculated subserosal leiomyomata with sequential uterine artery embolization and myomectomy. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17225969&form=6&db=m Magnetic resonance angiography of uterine artery: changes with embolization using gelatin sponge particles alone for fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17346524&form=6&db=m Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17377188&form=6&db=m Rabbit VX2 Tumors as an Animal Model of Uterine Fibroids and for Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17492540&form=6&db=m [Clinical 3-year follow-up of uterine fibroid embolization] diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17504316&form=6&db=m Uterine artery embolization for symptomatic fibroids with imaging follow up. diagnostic usage,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17515376&form=6&db=m Frequency and extent of uterine perfusion via ovarian arteries observed during uterine artery embolization for leiomyomas. diagnostic usage,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17547877&form=6&db=m Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17609441&form=6&db=m Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17671810&form=6&db=m Magnetic resonance imaging (MRI) analysis of fibroid location in women achieving pregnancy after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17688619&form=6&db=m Uterine artery embolization should not be recommended without careful consideration in the treatment of symptomatic uterine fibroids. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17694986&form=6&db=m Spontaneous vaginal expulsion of an infected necrotic cervical fibroid through a cervical fistula after uterine artery embolization: a case report. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17803657&form=6&db=m Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17909691&form=6&db=m Fibroid-induced acute urinary retention: treatment by uterine artery embolization. causal interaction,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17911509&form=6&db=m Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17923833&form=6&db=m Treatment of uterine fibroid via bilateral uterine artery embolization: state of the art. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17949376&form=6&db=m A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17949377&form=6&db=m Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17997392&form=6&db=m Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization. diagnostic usage,ongoing research,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18003985&form=6&db=m Use of a combined MR imaging and interventional radiology suite for intraprocedural monitoring of uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18057985&form=6&db=m MR reproducibility in the assessment of uterine fibroids for patients scheduled for uterine artery embolization. diagnostic usage,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18092295&form=6&db=m Is uterine artery embolization prior to myomectomy for giant fibroids helpful? ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18187401&form=6&db=m Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy--results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18192466&form=6&db=m Spherical versus conventional polyvinyl alcohol particles for uterine artery embolization. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18219521&form=6&db=m Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications? therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18295216&form=6&db=m Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18295689&form=6&db=m Long-term Outcome of Uterine Artery Embolization for Symptomatic Uterine Leiomyomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,2,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18295706&form=6&db=m Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328788&form=6&db=m Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. causal interaction,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18331704&form=6&db=m A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18341948&form=6&db=m Long-term Efficacy and Safety of Uterine Artery Embolization in Young Patients with and without Uteroovarian Anastomoses. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18344356&form=6&db=m Non-surgical management of uterine fibroids. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18395493&form=6&db=m Conventional myomectomy. causal interaction,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18418568&form=6&db=m [Long-term results after fibroid embolization.] causal interaction,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18430835&form=6&db=m Submucosal fibroids becoming endocavitary following uterine artery embolization: risk assessment by MRI. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18430836&form=6&db=m Are fibroids that become endocavitary after uterine artery embolization necessarily a complication? therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18439501&form=6&db=m Uterine artery embolization versus occlusion for uterine leiomyomas: a pilot randomized clinical trial. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18440452&form=6&db=m Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. causal interaction,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18440453&form=6&db=m Clinical failure after uterine artery embolization: evaluation of patient and MR imaging characteristics. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18520537&form=6&db=m Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using tris-acryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18521559&form=6&db=m [Imaging before and after uterine artery embolization.] causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18574626&form=6&db=m Uterine artery embolization for ureteric obstruction secondary to fibroids. causal interaction,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18589314&form=6&db=m Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. causal interaction,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18692808&form=6&db=m Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. causal interaction,therapeutic application,unassigned 4,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18824376&form=6&db=m Three-dimensional reconstructed contrast-enhanced MR angiography for internal iliac artery branch visualization before uterine artery embolization. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18837841&form=6&db=m What is the place of uterine artery embolisation in the management of symptomatic uterine fibroids? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19048334&form=6&db=m Spectrum of imaging findings on MRI and CT after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19172544&form=6&db=m Elevated level of plasma vascular endothelial growth factor after gonadotropin-releasing hormone agonist treatment for leiomyomata. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19232612&form=6&db=m Uterine artery embolization versus laparoscopic occlusion of uterine vessels for management of symptomatic uterine fibroids. causal interaction,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19361799&form=6&db=m Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. diagnostic usage,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19416573&form=6&db=m Femoral artery puncture site pseudoaneurysm formation following uterine artery embolization for symptomatic fibroids: a case report. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19640736&form=6&db=m Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. causal interaction,ongoing research,therapeutic application,unassigned 1,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19713130&form=6&db=m Uterine artery embolization versus laparoscopic occlusion of uterine arteries for leiomyomas: long-term results of a randomized comparative trial. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19804021&form=6&db=m Uterine artery embolization and future fertility potential. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20066419&form=6&db=m Uterine Artery Embolization in Patients with a Large Fibroid Burden: Long-Term Clinical and MR Follow-up. causal interaction,ongoing research,therapeutic application,unassigned 4,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20149688&form=6&db=m Leiomyoma volume changes at follow-up after uterine artery embolization: correlation with the initial leiomyoma volume and location. causal interaction,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20149690&form=6&db=m Prospective evaluation of the embolic agent bead block in the treatment of uterine leiomyomas with uterine artery embolization: a phase II study. ongoing research,therapeutic application,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20187204&form=6&db=m Preinterventional quantitative magnetic resonance imaging predicts uterus and leiomyoma size reduction after uterine artery embolization. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20332375&form=6&db=m Assessment of uterine and ovarian arteries before uterine artery embolization: advantages conferred by unenhanced MR angiography. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20382082&form=6&db=m Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolization. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20386442&form=6&db=m Impact of previous uterine artery embolization on fertility. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20392986&form=6&db=m Uterine Artery Embolization for Leiomyomas: Percentage of Infarction Predicts Clinical Outcome. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20414846&form=6&db=m Uterine artery embolization for fibroids: a review of current outcomes. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20432349&form=6&db=m Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20442999&form=6&db=m Does Size Really Matter? Analysis of the Effect of Large Fibroids and Uterine Volumes on Complication Rates of Uterine Artery Embolisation. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20465558&form=6&db=m The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20500955&form=6&db=m Fibroids treated with uterine artery embolization: do imaging findings correlate with patient outcomes? causal interaction,ongoing research,therapeutic application,unassigned 1,2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20574795&form=6&db=m Initial Experience of Uterine Fibroid Embolization Using Porous Gelatin Sponge Particles. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,1,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20579960&form=6&db=m Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20685136&form=6&db=m Effect of uterine artery embolization on uterine and leiomyoma perfusion: evidence of transient myometrial ischemia on magnetic resonance imaging. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20708528&form=6&db=m Placenta accreta following uterine artery embolization. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20814554&form=6&db=m Successful magnetic resonance imaging-guided focused ultrasound surgery for recurrent uterine fibroid previously treated with uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20884240&form=6&db=m Phase I/II multiinstitutional study of uterine artery embolization with gelatin sponge for symptomatic uterine leiomyomata: Japan interventional radiology in oncology study group study. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,4,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21112709&form=6&db=m Conservative two-step procedure including uterine artery embolization with embosphere and surgical myomectomy for the treatment of multiple fibroids: Preliminary experience. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21127866&form=6&db=m Comparison of the Efficacy of the Embolic Agents Acrylamido Polyvinyl Alcohol Microspheres and Tris-Acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomas: A Prospective Randomized Controlled Trial. diagnostic usage,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21584841&form=6&db=m Unenhanced MR Angiography of Uterine and Ovarian Arteries after Uterine Artery Embolization: Differences between Patients with Incomplete and Complete Fibroid Infarction. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21642637&form=6&db=m Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21773858&form=6&db=m Uterine Artery Embolization versus Myomectomy: Impact on Quality of Life-Results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. ongoing research,therapeutic application,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21850565&form=6&db=m Uterine Artery Embolization to Treat Uterine Adenomyosis with or without Uterine Leiomyomata: Results of Symptom Control and Health-Related Quality of Life 40 Months after Treatment. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21868811&form=6&db=m Implementation of uterine artery embolisation for symptomatic uterine fibroids: an inventory. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22135681&form=6&db=m Indications and outcomes of uterine artery embolization in patients with uterine leiomyomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22154588&form=6&db=m Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: Clinical and imaging results. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22173924&form=6&db=m Uterine Artery Embolization for Uterine Leiomyoma: Role of Uterine Artery Doppler in the Pre-Interventional, Interventional and Post-interventional Patient Workup. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22191046&form=6&db=m Uterine artery embolization as nonsurgical treatment of uterine myomas. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22221154&form=6&db=m Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - An interim report on an Australian experience. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22381440&form=6&db=m Treatment failure after uterine artery embolization: Prospective cohort study with multifactorial analysis of possible predictors of long-term outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22413857&form=6&db=m Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22413922&form=6&db=m Hysteroscopy after uterine fibroid embolization: Evaluation of intrauterine findings in 127 patients. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22526109&form=6&db=m Uterine Artery Embolization Versus Laparoscopic Uterine Artery Occlusion: The Outcomes of a Prospective, Nonrandomized Clinical Trial. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22675971&form=6&db=m Complicated abdominal hysterectomy subsequent to uterine embolization for large fibroids. diagnostic usage,therapeutic application,unassigned 4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22898156&form=6&db=m Diffusion-weighted imaging in uterine artery embolisation: do findings correlate with contrast enhancement and volume reduction? diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23070101&form=6&db=m Randomized Comparison of Uterine Artery Embolization (UAE) with Surgical Treatment in Patients with Symptomatic Uterine Fibroids (REST Trial): Subanalysis of 5-Year MRI Findings. causal interaction,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23226725&form=6&db=m Leiomyoma treatment by uterine artery embolization using gelatin sponge prepared by the pumping method. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23456309&form=6&db=m Midterm Results after Uterine Artery Embolization Versus MR-Guided High-Intensity Focused Ultrasound Treatment for Symptomatic Uterine Fibroids. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23470066&form=6&db=m Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23474384&form=6&db=m The effect of treatment preference and treatment allocation on patients' health-related quality of life in the randomized EMMY trial. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23701904&form=6&db=m Uterine artery embolization and its effect on fertility. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23992381&form=6&db=m Non spherical polyvinyl alcohol versus gelatin sponge particles for uterine artery embolization for symptomatic fibroids. causal interaction,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24099448&form=6&db=m Fibroid Infected With Escherichia Coli Requiring Surgical Removal Following Uterine Artery Embolization. causal interaction,therapeutic application,unassigned 2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24314563&form=6&db=m [Non-surgical approach for symptomatic fibroids. Physical methods: selective embolization]. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24594413&form=6&db=m Entropy of T2-weighted Imaging Combined with Apparent Diffusion Coefficient in Prediction of Uterine Leiomyoma Volume Response after Uterine Artery Embolization. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24612893&form=6&db=m Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24657088&form=6&db=m The Effect of Uterine Artery Embolization on Premenstrual Symptoms in Patients with Symptomatic Fibroids or Adenomyosis. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24693405&form=6&db=m Uterine Artery Embolization for Treatment of Symptomatic Fibroids: A Review of the Evidence. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25018653&form=6&db=m Embolization of uterine fibroids from the point of view of the gynecologist: pros and cons. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25055272&form=6&db=m MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25117743&form=6&db=m Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25251811&form=6&db=m Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25271135&form=6&db=m Prediction of early response to uterine artery embolization in fibroids: value of MR signal intensity ratio. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25694762&form=6&db=m Uterine artery embolization for treatment of symptomatic fibroids; a single institution experience. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25727093&form=6&db=m Anti Müllerian hormone levels before and after uterine artery embolization: A preliminary report. causal interaction,ongoing research,therapeutic application,unassigned 2,1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26100298&form=6&db=m Uterine artery embolization by use of porous gelatin particles for symptomatic uterine leiomyomas: comparison with hand-cut gelatin sponge particles. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26183465&form=6&db=m Can (1)H MR Spectroscopy be Used to Assess the Success of Uterine Artery Embolisation? causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,1,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26288491&form=6&db=m Uterine artery embolisation for uterine fibroids: Our experience at a tertiary care service hospital. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26327862&form=6&db=m Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26357531&form=6&db=m Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis. ongoing research,therapeutic application,unassigned 4,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26372352&form=6&db=m Uterine artery embolization for symptomatic fibroids in postmenopausal women. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,1,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26414280&form=6&db=m Uterine artery embolization using progressively larger calibrated gelatin sponge particles. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26536205&form=6&db=m Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26630074&form=6&db=m Current Role of Uterine Artery Embolization in the Management of Uterine Fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26667403&form=6&db=m The effects of single-dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26756068&form=6&db=m Uterine artery embolization for heavy menstrual bleeding. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26801165&form=6&db=m Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26817928&form=6&db=m Low vascularity predicts favourable outcomes in leiomyoma patients treated with uterine artery embolization. diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26893660&form=6&db=m IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26925914&form=6&db=m Clinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids. diagnostic usage,therapeutic application,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27533290&form=6&db=m Management of Uterine Fibroids: A Focus on Uterine-sparing Interventional Techniques. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27574469&form=6&db=m Efficacies of uterine artery embolization for symptomatic uterine fibroids using gelatin sponge: a single-center experience and literature review. diagnostic usage,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27697621&form=6&db=m The effects of uterine artery embolization on ovarian reserve. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27799569&form=6&db=m Tris-acryl gelatin microspheres versus gelatin sponge particles in uterine artery embolization for leiomyoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,1,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28163256&form=6&db=m Preprocedural MRI and MRA in planning fibroid embolization. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28318365&form=6&db=m Effects of TGF-? on uterine fibroids of women of childbearing age and uterine artery embolization. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28508254&form=6&db=m Comparison of Pain Within 24 h after Uterine Artery Embolization with Tris-Acryl Gelatin Microspheres Versus Gelatin Sponge Particles for Leiomyoma. diagnostic usage,therapeutic application,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28516272&form=6&db=m Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28536870&form=6&db=m Benign Metastasizing Leiomyomas Following Myomectomy and Uterine Artery Embolization. causal interaction,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28635407&form=6&db=m Ovarian reserve after fibroid embolization in premenopausal women. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28639830&form=6&db=m First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28670051&form=6&db=m Ineffectiveness of magnetic resonance imaging enhancement to predict fibroid volume reduction after uterine artery embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,3,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28807810&form=6&db=m Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28876143&form=6&db=m Anti-Müllerian hormone levels before and after uterine artery embolization. causal interaction,ongoing research,therapeutic application,unassigned 2,2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28929111&form=6&db=m Monitoring Leiomyoma Response to Uterine Artery Embolization Using Diffusion and Perfusion Indices from Diffusion-Weighted Imaging. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28951427&form=6&db=m An unexpected complication following uterine artery embolisation. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29052017&form=6&db=m Fertility after uterine artery embolization of fibroids: a systematic review. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29090348&form=6&db=m Characteristics of a New X-Ray Imaging System for Interventional Procedures: Improved Image Quality and Reduced Radiation Dose. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29138718&form=6&db=m Comparing the Use of Uterine Artery Embolization to Gonadotropin-Releasing Hormone Agonists in Shrinking Fibroid Size: A Pilot Study in Kazakhstan. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29352594&form=6&db=m Systematic review of uterine artery embolisation practice guidelines: are all the guidelines on the same page? diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29423450&form=6&db=m Color Doppler Ultrasound in Uterine Arterial Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29477623&form=6&db=m Uterine Artery Embolization for Pedunculated Subserosal Leiomyomas: Evidence of Safety and Efficacy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,4 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29628616&form=6&db=m Updates on Uterine Artery Embolization. causal interaction,ongoing research,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29777846&form=6&db=m An Academic Tertiary Referral Center's Experience with a Vascular Surgery-Based Uterine Artery Embolization Program. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29859107&form=6&db=m Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study. diagnostic usage,therapeutic application,unassigned 3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30261778&form=6&db=m Volume of embolic agents in uterine artery embolization for leiomyoma: relation to baseline MRI. unassigned - 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30527317&form=6&db=m Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30588202&form=6&db=m Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30654161&form=6&db=m Susceptibility weighted MRI after uterine artery embolization for leiomyoma. ongoing research,therapeutic application,unassigned 3,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30676099&form=6&db=m Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. causal interaction,therapeutic application,unassigned 4,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30766459&form=6&db=m Uterine artery embolization in the treatment of symptomatic fibroids - state of the art 2018. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30835520&form=6&db=m Uterine Artery Embolization in Patients With Autoimmune Disease: A Matched Case-Control Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30952521&form=6&db=m Insufficient Leiomyoma Infarction in Uterine Artery Embolization: Relationship with Tumor Location. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31123385&form=6&db=m Fibroid Expulsion after Uterine Artery Embolization. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31137043&form=6&db=m Uterine Artery Embolization (UAE) for Fibroid Treatment - Results of the 7th Radiological Gynecological Expert Meeting. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31354165&form=6&db=m Uterine Artery Embolization (UAE) for Fibroid Treatment - Results of the 7th Radiological Gynecological Expert Meeting. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31493956&form=6&db=m Oxytocin-Augmented and Non-Sedating High-Intensity-Focused Ultrasound (HIFU) for Uterine Fibroids Showed Promising Outcome As Compared To HIFU Alone or Uterine Artery Embolization. causal interaction,diagnostic usage,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31544371&form=6&db=m Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31650245&form=6&db=m Predicting the Fibroid-Migratory Impact of UAE: Role of Pre-embolization MRI Characteristics. causal interaction,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31784332&form=6&db=m Intra-Arterial Lidocaine Administration for Anesthesia after Uterine Artery Embolization with Trisacryl Gelatin Microspheres for Leiomyoma. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31792586&form=6&db=m Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis. causal interaction,ongoing research,therapeutic application,unassigned 1,2,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32026034&form=6&db=m Implementation of uterine artery embolization for symptomatic fibroids in the Netherlands: an inventory and preference study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32062997&form=6&db=m Efficacy of Intraprocedural Superior Hypogastric Nerve Block in Reduction of Postuterine Artery Embolization Narcotic Analgesia Use. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32081542&form=6&db=m Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32093446&form=6&db=m Shearwave elastographic evaluation of uterine leiomyomas after uterine artery embolization: preliminary results. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32141044&form=6&db=m Intraoperative microvascular assessment with contrast-enhanced ultrasound (CEUS) during uterine artery embolisation (UAE): a case report and literature review. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32181148&form=6&db=m Pyomyoma after uterine artery embolization: A case report. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32487798&form=6&db=m Updates in uterine artery embolization for leiomyomas. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32685318&form=6&db=m Comparing Perioperative Outcomes of Uterine Artery Embolization and Hysterectomy in Insurer and Demographically Diverse Populations: A Retrospective, Multi-Center Database Study. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32742370&form=6&db=m Value of Dyna CT in guiding embolization during transarterial uterine artery embolization of fibroids. diagnostic usage,therapeutic application,unassigned 1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32882725&form=6&db=m Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids - A Retrospective Evaluation. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33197612&form=6&db=m Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33204553&form=6&db=m Diagnosis of Leiomyosarcoma after Uterine Artery Embolization for Multiple Leiomyomas. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33239156&form=6&db=m Contrast-Enhanced Ultrasound for Monitoring Non-surgical Treatments of Uterine Fibroids: A Systematic Review. ongoing research,therapeutic application,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33350893&form=6&db=m Nonspherical Polyvinyl Alcohol Particles versus Tris-Acryl Microspheres: Randomized Controlled Trial Comparing Pain after Uterine Artery Embolization for Symptomatic Fibroids. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33468366&form=6&db=m Timing of Uterine Artery Embolization for Leiomyoma during the Menstrual Cycle. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,3,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33534624&form=6&db=m Single-System Experience With Outpatient Transradial Uterine Artery Embolization: Safety, Feasibility, Outcomes, and Early Rates of Return. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33594913&form=6&db=m Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33599335&form=6&db=m The Diagnostic Value of Superb Microvascular Imaging in Prediction of Uterine Artery Embolization Treatment Response in Uterine Leiomyomas. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33667943&form=6&db=m Combination uterine artery embolization and hysteroscopic resection for a symptomatic uterine leiomyoma: A collaborative single-session approach for better patient care. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33788039&form=6&db=m Initial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34012498&form=6&db=m Microspheres vaginal discharge as a complication after Uterine Artery Embolization for intramural/submucosal fibroid. causal interaction,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34053154&form=6&db=m Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34195889&form=6&db=m Comparison of 1.5 T and 3 T non-contrast-enhanced MR angiography for visualization of uterine and ovarian arteries before uterine artery embolization. therapeutic application,unassigned 4,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34242085&form=6&db=m Uterine and Fibroid Imaging Analysis from the FIRSTT Study. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34290527&form=6&db=m Uterine Artery Embolization with Small-Sized Particles for the Treatment of Symptomatic Adenomyosis: A 42-Month Clinical Follow-Up. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34420449&form=6&db=m The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. therapeutic application,unassigned 2,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34426775&form=6&db=m Observation of Intramural Fibroid Expulsion on MRI after Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,2 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34476193&form=6&db=m Uterine artery embolization, surgery and high intensity focused ultrasound in the treatment of uterine fibroids: a network meta-analysis. therapeutic application,unassigned 3,0 5.1.3.7 Leiomyoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34540304&form=6&db=m Myoma Expulsion after Uterine Artery Embolization. therapeutic application,unassigned 1,0 5.1.3.7 Leiomyomatosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22154588&form=6&db=m Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: Clinical and imaging results. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,4 5.1.3.7 Leiomyosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17083970&form=6&db=m Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Leiomyosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17803657&form=6&db=m Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Leiomyosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19480255&form=6&db=m Metastatic leiomyosarcoma diagnosed after uterine artery embolization. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Leiomyosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33204553&form=6&db=m Diagnosis of Leiomyosarcoma after Uterine Artery Embolization for Multiple Leiomyomas. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Leukemia, Myeloid, Acute http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19557635&form=6&db=m Acute leukemia among the adult population of United Arab Emirates: an epidemiological study. causal interaction,unassigned 2,0 5.1.3.7 Leukocytosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18295706&form=6&db=m Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19087704&form=6&db=m [Treatment of pregnancy in a previous caesarean section scar with uterine artery embolization: analysis of 60 cases] diagnostic usage,unassigned 2,0 5.1.3.7 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29956688&form=6&db=m Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. diagnostic usage,unassigned 1,0 5.1.3.7 Lupus Erythematosus, Systemic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8944210&form=6&db=m Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. diagnostic usage,unassigned 3,0 5.1.3.7 Lupus Erythematosus, Systemic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27831539&form=6&db=m Incidence and prevalence of systemic lupus erythematosus among the native Arab population in UAE. unassigned - 5.1.3.7 Lupus Nephritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9227170&form=6&db=m Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Lupus Nephritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540895&form=6&db=m Pattern of acute glomerulonephritis in adult population in Dubai: A single-center experience. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Lymphadenitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34101753&form=6&db=m Pathology, bacteriology and molecular studies on caseous lymphadenitis in Camelus dromedarius in the Emirate of Abu Dhabi, UAE, 2015-2020. unassigned - 5.1.3.7 Lymphoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15160917&form=6&db=m Urinary albumin excretion is a predictor of response to treatment and disease progression in low-grade non-Hodgkin's lymphoma. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,3,0 5.1.3.7 Lymphoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31111763&form=6&db=m Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells. causal interaction,ongoing research,therapeutic application,unassigned 4,3,3,0 5.1.3.7 Lymphoma, Mantle-Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31111763&form=6&db=m Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells. causal interaction,ongoing research,therapeutic application,unassigned 4,3,3,0 5.1.3.7 Lymphoma, Non-Hodgkin http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10606899&form=6&db=m Clinical significance of urinary albumin excretion in patients with non-Hodgkin's lymphoma. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 5.1.3.7 Lymphoma, Non-Hodgkin http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12694249&form=6&db=m Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphoma. diagnostic usage,unassigned 4,0 5.1.3.7 Lymphoma, Non-Hodgkin http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15160917&form=6&db=m Urinary albumin excretion is a predictor of response to treatment and disease progression in low-grade non-Hodgkin's lymphoma. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,3,0 5.1.3.7 Macular Edema http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31637196&form=6&db=m Association of urinary albumin excretion with central foveal thickness and intravitreal conbercept treatment frequency in patients with diabetic macular edema. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Macular Edema http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33426902&form=6&db=m Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9337002&form=6&db=m Effect of previous chloroquine intake on in vivo P. falciparum drug sensitivity. therapeutic application,unassigned 1,0 5.1.3.7 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19724695&form=6&db=m Imported malaria in United Arab Emirates: evaluation of a new DNA extraction technique using nested PCR. unassigned - 5.1.3.7 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34361867&form=6&db=m Current Epidemiological Characteristics of Imported Malaria, Vector Control Status and Malaria Elimination Prospects in the Gulf Cooperation Council (GCC) Countries. therapeutic application,unassigned 1,0 5.1.3.7 Mastitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32493341&form=6&db=m Gangrenous mastitis in dromedary camels in UAE caused by Streptococcus agalactiae. diagnostic usage,unassigned 3,0 5.1.3.7 Measles http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32110548&form=6&db=m Evaluation of knowledge of the United Arab Emirates population on measles and its control, following a nationwide campaign. ongoing research,therapeutic application,unassigned 3,1,0 5.1.3.7 Menopause, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14551282&form=6&db=m Coil embolization of a tuboovarian anastomosis before uterine artery embolization to prevent nontarget particle embolization of the ovary. causal interaction,unassigned 2,0 5.1.3.7 Menopause, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16553656&form=6&db=m Long-term follow up of uterine artery embolisation-an effective alternative in the treatment of fibroids. therapeutic application,unassigned 1,0 5.1.3.7 Menopause, Premature http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28250724&form=6&db=m The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes - a review of literature. causal interaction,unassigned 4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10319310&form=6&db=m Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases. therapeutic application,unassigned 3,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12399085&form=6&db=m Uterine artery embolization for the treatment of uterine leiomyomata. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12524074&form=6&db=m The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. therapeutic application,unassigned 1,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12525582&form=6&db=m Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. causal interaction,therapeutic application,unassigned 2,2,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14563603&form=6&db=m [Uterine fibroids embolization: results about 454 cases] diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15797303&form=6&db=m Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16923975&form=6&db=m A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17185691&form=6&db=m Treatment of intrauterine and large pedunculated subserosal leiomyomata with sequential uterine artery embolization and myomectomy. therapeutic application,unassigned 4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17199918&form=6&db=m [Intermediate and long term clinical effects of uterine arterial embolization in treatment of adenomyosis] causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18187401&form=6&db=m Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy--results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,2,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20526776&form=6&db=m Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial. therapeutic application,unassigned 1,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20884240&form=6&db=m Phase I/II multiinstitutional study of uterine artery embolization with gelatin sponge for symptomatic uterine leiomyomata: Japan interventional radiology in oncology study group study. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,4,2 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21868811&form=6&db=m Implementation of uterine artery embolisation for symptomatic uterine fibroids: an inventory. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22135681&form=6&db=m Indications and outcomes of uterine artery embolization in patients with uterine leiomyomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,2 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22413857&form=6&db=m Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26756068&form=6&db=m Uterine artery embolization for heavy menstrual bleeding. therapeutic application,unassigned 3,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28951427&form=6&db=m An unexpected complication following uterine artery embolisation. therapeutic application,unassigned 1,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30527317&form=6&db=m Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32882725&form=6&db=m Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids - A Retrospective Evaluation. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33204553&form=6&db=m Diagnosis of Leiomyosarcoma after Uterine Artery Embolization for Multiple Leiomyomas. causal interaction,therapeutic application,unassigned 1,4,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33788039&form=6&db=m Initial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Menorrhagia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34540304&form=6&db=m Myoma Expulsion after Uterine Artery Embolization. therapeutic application,unassigned 1,0 5.1.3.7 Mesothelioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19344084&form=6&db=m [In Process Citation] therapeutic application,unassigned 2,0 5.1.3.7 Metabolic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30706787&form=6&db=m Growth of diabetes research in United Arab Emirates: current and future perspectives. causal interaction,unassigned 2,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16186291&form=6&db=m Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. causal interaction,diagnostic usage,unassigned 4,4,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16936988&form=6&db=m [Evaluation of microalbuminuria in non-diabetic individuals] causal interaction,unassigned 4,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17998025&form=6&db=m The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,1,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18632180&form=6&db=m Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18699721&form=6&db=m The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. causal interaction,unassigned 2,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18854761&form=6&db=m Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19046248&form=6&db=m Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20032259&form=6&db=m Metabolic Syndrome among the Young Obese in the United Arab Emirates. causal interaction,diagnostic usage,unassigned 4,4,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22253539&form=6&db=m Effect of Ramadan fasting on metabolic markers, body composition, and dietary intake in Emiratis of Ajman (UAE) with metabolic syndrome. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22670702&form=6&db=m Have main types of primary aldosteronism different phenotype? unassigned - 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23278488&form=6&db=m Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? diagnostic usage,unassigned 1,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23390836&form=6&db=m The metabolic syndrome is associated with high-normal urinary albumin excretion and retinopathy in normoalbuminuric type 1 diabetic patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26758793&form=6&db=m Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Metabolic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30273662&form=6&db=m The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population. unassigned - 5.1.3.7 Mouth Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23985381&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Mouth Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28156221&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Multiple Myeloma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30737236&form=6&db=m Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Multiple Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26240760&form=6&db=m Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study. therapeutic application,unassigned 1,0 5.1.3.7 Multiple Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26576071&form=6&db=m Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Multiple Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29619159&form=6&db=m Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates. ongoing research,unassigned 1,0 5.1.3.7 Murine Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30109280&form=6&db=m PREVALENCE OF CRYPTOSPORIDIUM SPP. AMONG ASYMPTOMATIC HEALTHY EXPATRIATE WORKERS IN SHARJAH, UNITED ARAB EMIRATES. diagnostic usage,ongoing research,unassigned 2,1,0 5.1.3.7 Muscle Cramp http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32882725&form=6&db=m Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids - A Retrospective Evaluation. ongoing research,therapeutic application,unassigned 2,2,0 5.1.3.7 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11411973&form=6&db=m EKG analysis skills of family practice residents in the United Arab Emirates: a comparison with US data. diagnostic usage,unassigned 1,0 5.1.3.7 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16374441&form=6&db=m Microalbuminuria in patients with previous myocardial infarction. causal interaction,diagnostic usage,unassigned 4,2,0 5.1.3.7 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26734321&form=6&db=m Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction In Primary Percutaneous Intervention: Transformation using Robust Performance Improvement. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33616911&form=6&db=m Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort. causal interaction,unassigned 3,0 5.1.3.7 Myocardial Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8630672&form=6&db=m Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: relevance to cardiovascular disease. causal interaction,diagnostic usage,unassigned 1,3,0 5.1.3.7 Myocardial Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130259&form=6&db=m Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. causal interaction,unassigned 4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11953055&form=6&db=m [Clinical analysis of 42 cases uterine myoma by uterine arterial embolization] diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11960052&form=6&db=m Ischemic uterine rupture and hysterectomy 3 months after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12525461&form=6&db=m Incomplete vaginal expulsion of pyoadenomyoma with sepsis and focal bladder necrosis after uterine artery embolization for symptomatic adenomyosis: case report. diagnostic usage,therapeutic application,unassigned 3,2,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14563603&form=6&db=m [Uterine fibroids embolization: results about 454 cases] diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15559347&form=6&db=m Ovarian function after uterine artery embolization and hysterectomy. diagnostic usage,unassigned 3,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16579996&form=6&db=m Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16923975&form=6&db=m A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17053762&form=6&db=m [Effect of technical and anatomical factors on efficacy of embolization of uterine arteries] causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17199927&form=6&db=m [Meta-analysis of uterine arterial embolization and myomectomy in treatment of uterine myoma] causal interaction,ongoing research,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18430385&form=6&db=m Septic uterus after uterine artery embolization for uterine myomas triggered by endometrial biopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18486095&form=6&db=m Intraabdominal adhesions after uterine artery embolization. causal interaction,diagnostic usage,unassigned 2,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20226411&form=6&db=m The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma. diagnostic usage,therapeutic application,unassigned 1,2,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22413922&form=6&db=m Hysteroscopy after uterine fibroid embolization: Evaluation of intrauterine findings in 127 patients. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22526109&form=6&db=m Uterine Artery Embolization Versus Laparoscopic Uterine Artery Occlusion: The Outcomes of a Prospective, Nonrandomized Clinical Trial. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23602353&form=6&db=m [Uterine artery embolization for myomas treatment]. therapeutic application,unassigned 2,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25368788&form=6&db=m Anesthetic management of a parturient with placenta previa totalis undergoing preventive uterine artery embolization before placental expulsion during cesarean delivery: a case report. causal interaction,ongoing research,unassigned 3,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25975130&form=6&db=m [Results of uterine artery embolization in the treatment of symptomatic uterine myoma]. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26309526&form=6&db=m Tri-acryl gelatin microsphere is better than polyvinyl alcohol in the treatment of uterine myomas with uterine artery embolization. therapeutic application,unassigned 4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26550414&form=6&db=m Effects of the intermittent injection with super-low pressure on the postoperative pain control during the uterine artery embolization for uterine myoma. ongoing research,therapeutic application,unassigned 4,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26633901&form=6&db=m Uterine Fibroid Embolisation - Potential Impact on Fertility and Pregnancy Outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28807810&form=6&db=m Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29179628&form=6&db=m Pregnancy after uterine artery embolization using Gelfoam™. therapeutic application,unassigned 3,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29969685&form=6&db=m Multidisciplinary Approach in Large-sized Submucosal Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30588202&form=6&db=m Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30807812&form=6&db=m Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31741842&form=6&db=m Evaluation of Uterine Artery Embolization on Myoma Shrinkage: Results from a Large Cohort Analysis. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,4,4 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32841756&form=6&db=m Nonextirpative Treatments for Uterine Myomas: Measuring Success. unassigned - 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32917320&form=6&db=m Comparison of magnetic resonance-guided high-intensity focused ultrasound with uterine artery embolization for the treatment of uterine myoma: A systematic literature review and meta-analysis. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33197612&form=6&db=m Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,1 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33399491&form=6&db=m Sepsis following hysteroscopic myomectomy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,4,0 5.1.3.7 Myoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33550765&form=6&db=m Can pre-procedural MRI signal intensity ratio predict the success of uterine artery embolization in treatment of myomas? causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,1,4 5.1.3.7 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14501709&form=6&db=m Prognostic significance of albuminuria in patients with renal cell cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17803657&form=6&db=m Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19480255&form=6&db=m Metastatic leiomyosarcoma diagnosed after uterine artery embolization. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23985381&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28156221&form=6&db=m Oral cancer in the UAE: a multicenter, retrospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,2 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9096700&form=6&db=m Socioeconomic factors in the families of children with lymphoid malignancy in the UAE. unassigned - 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718833&form=6&db=m Increased urinary albumin excretion in Cushing's syndrome: remission after correction of hypercortisolaemia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12694249&form=6&db=m Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphoma. diagnostic usage,unassigned 4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14501709&form=6&db=m Prognostic significance of albuminuria in patients with renal cell cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 2,4,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14514150&form=6&db=m Urinary albumin excretion and its relationship to C-reactive protein and proinflammatory cytokines in patients with cancer and febrile neutropenia. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14605104&form=6&db=m Leiomyoma recurrence after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15136105&form=6&db=m Quantified short-term outcome of uterine artery embolization with gelatin sponge particles and lipiodol for symptomatic myoma. causal interaction,therapeutic application,unassigned 4,2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15284321&form=6&db=m Quality of age data in patients from developing countries. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15958862&form=6&db=m Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. causal interaction,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16319148&form=6&db=m Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16319152&form=6&db=m Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16923975&form=6&db=m A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17083970&form=6&db=m Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17225969&form=6&db=m Magnetic resonance angiography of uterine artery: changes with embolization using gelatin sponge particles alone for fibroids. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17377188&form=6&db=m Rabbit VX2 Tumors as an Animal Model of Uterine Fibroids and for Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17803657&form=6&db=m Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17911509&form=6&db=m Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18003985&form=6&db=m Use of a combined MR imaging and interventional radiology suite for intraprocedural monitoring of uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18192468&form=6&db=m Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18295689&form=6&db=m Long-term Outcome of Uterine Artery Embolization for Symptomatic Uterine Leiomyomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,2,4 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18440452&form=6&db=m Outcomes after uterine artery embolization for pedunculated subserosal leiomyomas. causal interaction,unassigned 1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18444921&form=6&db=m Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. diagnostic usage,unassigned 4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19417196&form=6&db=m Microalbuminuria and risk of venous thromboembolism. diagnostic usage,unassigned 2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19731776&form=6&db=m Incidence of cancer in Gulf Cooperation Council countries, 1998-2001. causal interaction,ongoing research,unassigned 1,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20432349&form=6&db=m Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22126512&form=6&db=m A commentary on delayed presentation of breast cancer in singapore. unassigned - 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23084766&form=6&db=m Tackling cancer burden in the Middle East: Qatar as an example. unassigned - 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25217421&form=6&db=m Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26327862&form=6&db=m Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27799569&form=6&db=m Tris-acryl gelatin microspheres versus gelatin sponge particles in uterine artery embolization for leiomyoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,1,4 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28479027&form=6&db=m Leiomyoma Infarction after Uterine Artery Embolization: Influence of Embolic Agent and Leiomyoma Size and Location on Outcome. therapeutic application,unassigned 1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28639830&form=6&db=m First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,1 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29334375&form=6&db=m A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. diagnostic usage,therapeutic application,unassigned 1,4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29607823&form=6&db=m Risk Factors of Cancer in the United Arab Emirates. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29777908&form=6&db=m Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29910835&form=6&db=m Supportive care needs of multicultural patients with cancer in the United Arab Emirates. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30068798&form=6&db=m Response Surface Methodology for Optimizing the Ultrasound-Assisted Extraction of Polysaccharides from Acanthopanax giraldii. causal interaction,unassigned 2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30141313&form=6&db=m Colorectal Cancer Risk Awareness and Screening Uptake among Adults in the United Arab Emirates causal interaction,unassigned 1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30519286&form=6&db=m Thyroid malignancy among patients with thyroid nodules in the United Arab Emirates: a five-year retrospective tertiary Centre analysis. causal interaction,unassigned 3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30558043&form=6&db=m The epidemiology of cancer in the United Arab Emirates: A systematic review. ongoing research,unassigned 3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30744593&form=6&db=m Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30847701&form=6&db=m Comparison of perceptions of unmet supportive care needs between cancer patients and their oncologists. unassigned - 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30898949&form=6&db=m Congenital hepatoblastoma in a growing health economy. unassigned - 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30952521&form=6&db=m Insufficient Leiomyoma Infarction in Uterine Artery Embolization: Relationship with Tumor Location. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31111763&form=6&db=m Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells. causal interaction,ongoing research,therapeutic application,unassigned 4,3,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31544371&form=6&db=m Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32044611&form=6&db=m Age-dependent effective ingestion dose estimations and lifetime risk assessment for selected radionuclides (40K and 3H) in bottled waters marketed in United Arab Emirates. diagnostic usage,unassigned 4,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32342923&form=6&db=m The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,3 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32344867&form=6&db=m Assessing the Knowledge of Environmental Risk Factors for Cancer among the UAE Population: A Pilot Study. ongoing research,therapeutic application,unassigned 4,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32650756&form=6&db=m Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task force. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32795357&form=6&db=m Epidemiology of brain tumors in the United Arab Emirates: a National Registry Cross-sectional Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,4,1 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33046991&form=6&db=m Negative Effects On Cancer Care Due To COVID-19 Implications: Observations From A Cancer Center In The UAE. ongoing research,therapeutic application,unassigned 3,1,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33115685&form=6&db=m Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,2 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33754294&form=6&db=m Knowledge, Attitudes, and Practices Concerning Breast Cancer and Self Examination Among Females in UAE. ongoing research,unassigned 2,0 5.1.3.7 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34540304&form=6&db=m Myoma Expulsion after Uterine Artery Embolization. therapeutic application,unassigned 1,0 5.1.3.7 Nephrosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1528348&form=6&db=m Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Nephrosis, Lipoid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540895&form=6&db=m Pattern of acute glomerulonephritis in adult population in Dubai: A single-center experience. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Nephrotic Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9227170&form=6&db=m Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Neurofibromatoses http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24413922&form=6&db=m The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE. ongoing research,unassigned 2,0 5.1.3.7 Neurofibromatosis 1 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24413922&form=6&db=m The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE. ongoing research,unassigned 2,0 5.1.3.7 Neuronal Ceroid-Lipofuscinoses http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23430803&form=6&db=m Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates : LSD in UAE. diagnostic usage,unassigned 1,0 5.1.3.7 Nocturnal Enuresis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16938508&form=6&db=m The genetic basis of inherited primary nocturnal enuresis: a UAE study. diagnostic usage,ongoing research,unassigned 4,2,0 5.1.3.7 Non-alcoholic Fatty Liver Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19242728&form=6&db=m Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,1 5.1.3.7 Non-alcoholic Fatty Liver Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29956688&form=6&db=m Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. diagnostic usage,unassigned 1,0 5.1.3.7 Non-alcoholic Fatty Liver Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33003574&form=6&db=m Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7550525&form=6&db=m Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,4,1 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11534041&form=6&db=m Prevalence of obesity among school children in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12745194&form=6&db=m Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15581333&form=6&db=m Hypertension and microalbuminuria: the new detrimental duo. causal interaction,unassigned 1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788356&form=6&db=m Childhood obesity in United Arab Emirates schoolchildren: a national study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16005369&form=6&db=m Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. causal interaction,unassigned 3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16179893&form=6&db=m Microalbuminuria and hypertension. causal interaction,unassigned 3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18091752&form=6&db=m Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18259102&form=6&db=m Prevalence of increased albumin excretion rate in young saudi adults. causal interaction,unassigned 4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18331704&form=6&db=m A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20059569&form=6&db=m Barriers and facilitators of weight management: perspectives of Arab women at risk for type 2 diabetes. diagnostic usage,therapeutic application,unassigned 2,3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20546144&form=6&db=m The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. causal interaction,unassigned 3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20566529&form=6&db=m Global public health and the United Arab Emirates. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22176929&form=6&db=m [Determination of urinary albumin excretion in arterial hypertension.] ongoing research,unassigned 2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22890490&form=6&db=m The prevalence and potential determinants of obesity among school children and adolescents in Abu Dhabi, United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23113084&form=6&db=m The Use of Obesity Indicators for the Prediction of Hypertension Risk among Youth in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23278488&form=6&db=m Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? diagnostic usage,unassigned 1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23470495&form=6&db=m Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. causal interaction,diagnostic usage,unassigned 2,4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24464020&form=6&db=m The role of adiponectin in renal physiology and development of albuminuria. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25371907&form=6&db=m Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study. diagnostic usage,ongoing research,unassigned 4,2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25586553&form=6&db=m A novel approach to systematic random sampling in population surveys: Lessons from the United Arab Emirates National Diabetes Study (UAEDIAB). diagnostic usage,ongoing research,unassigned 4,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25885030&form=6&db=m Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates--a cross-sectional study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25892603&form=6&db=m Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial. unassigned - 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27414402&form=6&db=m A Cross-Sectional Study of the Prevalence of Metabolic Syndrome among Young Female Emirati Adults. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27818779&form=6&db=m Increasing obesity rates in school children in United Arab Emirates. ongoing research,unassigned 4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28070158&form=6&db=m Obesity and Sleep-Related Breathing Disorders in Middle East and UAE. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29118852&form=6&db=m Prevalence of overweight and obesity in United Arab Emirates Expatriates: the UAE National Diabetes and Lifestyle Study. causal interaction,ongoing research,unassigned 3,2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29204365&form=6&db=m The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29343214&form=6&db=m Establishing a genetic link between FTO and VDR gene polymorphisms and obesity in the Emirati population. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29698434&form=6&db=m Evaluation of a photographic food atlas as a tool for quantifying food portion size in the United Arab Emirates. therapeutic application,unassigned 2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29717269&form=6&db=m Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE. diagnostic usage,unassigned 3,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30214265&form=6&db=m Efficacy of bariatric surgery in improving metabolic outcomes in patients with diabetes. A 24-month follow-up study from a single center in the UAE. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30217931&form=6&db=m Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose or Impaired Glucose Tolerance. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30273662&form=6&db=m The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population. unassigned - 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30372696&form=6&db=m Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30652030&form=6&db=m The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31405679&form=6&db=m Added sugar: Nutritional knowledge and consumption pattern of a principal driver of obesity and diabetes among undergraduates in UAE. unassigned - 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31592445&form=6&db=m Prevalence of diabetes and cardio-metabolic risk factors in young men in the United Arab Emirates: A cross-sectional national survey. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31767874&form=6&db=m Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. causal interaction,diagnostic usage,unassigned 1,4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31788465&form=6&db=m Nutrition in the Prevention of Breast Cancer: A Middle Eastern Perspective. unassigned - 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32109558&form=6&db=m Implication of genetic variants in overweight and obesity susceptibility among the young Arab population of the United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32340285&form=6&db=m An Integrative Phenotype-Genotype Approach Using Phenotypic Characteristics from the UAE National Diabetes Study Identifies HSD17B12 as a Candidate Gene for Obesity and Type 2 Diabetes. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,3,1 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32415247&form=6&db=m Obesity and Diabetes in an Arab population: Role of Adenovirus 36 Infection. causal interaction,unassigned 4,0 5.1.3.7 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32502178&form=6&db=m Obesity and its associated risk factors among school-aged children in Sharjah, UAE. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9622336&form=6&db=m Urinary albumin excretion and heart rate variability in obese women. causal interaction,unassigned 4,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12745194&form=6&db=m Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20627763&form=6&db=m [Albuminuria during the screening for diabetes in a semi-rural area (Kisantu City, DR Congo).] therapeutic application,unassigned 1,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25885030&form=6&db=m Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates--a cross-sectional study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26379278&form=6&db=m Are Microalbuminuria and Elevated 24 H Urinary Microalbumin Excretion within Normal Range Associated with Metabolic Syndrome in Chinese Adults? causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Obesity, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27440160&form=6&db=m Inflammatory markers and cardiovascular risks among overweight-obese Emirati women. causal interaction,unassigned 3,0 5.1.3.7 Obesity, Morbid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11534041&form=6&db=m Prevalence of obesity among school children in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 5.1.3.7 Osteoarthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34040400&form=6&db=m Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial. therapeutic application,unassigned 3,0 5.1.3.7 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31619919&form=6&db=m Pathophysiology of the Risk Factors Associated with Osteoporosis and their Correlation to the T-score Value in Patients with Osteopenia and Osteoporosis in the United Arab Emirates. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32700153&form=6&db=m Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries' osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). unassigned - 5.1.3.7 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33115685&form=6&db=m Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,2 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11902818&form=6&db=m Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14595867&form=6&db=m Prevalence of overweight among adolescent females in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14763657&form=6&db=m Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788356&form=6&db=m Childhood obesity in United Arab Emirates schoolchildren: a national study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16580581&form=6&db=m Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. diagnostic usage,unassigned 1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17212792&form=6&db=m Prevalence of overweight and obesity among children in the United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20546144&form=6&db=m The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. causal interaction,unassigned 3,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22890490&form=6&db=m The prevalence and potential determinants of obesity among school children and adolescents in Abu Dhabi, United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25885030&form=6&db=m Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates--a cross-sectional study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27414402&form=6&db=m A Cross-Sectional Study of the Prevalence of Metabolic Syndrome among Young Female Emirati Adults. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,2 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29118852&form=6&db=m Prevalence of overweight and obesity in United Arab Emirates Expatriates: the UAE National Diabetes and Lifestyle Study. causal interaction,ongoing research,unassigned 3,2,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29698434&form=6&db=m Evaluation of a photographic food atlas as a tool for quantifying food portion size in the United Arab Emirates. therapeutic application,unassigned 2,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30273662&form=6&db=m The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population. unassigned - 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30372696&form=6&db=m Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,4,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30652030&form=6&db=m The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis. ongoing research,therapeutic application,unassigned 1,1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31159801&form=6&db=m Total adiponectin in overweight and obese subjects and its response to visceral fat loss. diagnostic usage,ongoing research,unassigned 2,3,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32109558&form=6&db=m Implication of genetic variants in overweight and obesity susceptibility among the young Arab population of the United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32568122&form=6&db=m A review of gestational diabetes mellitus management, risk factors, maternal and neonatal outcomes in two major maternity hospitals in the United Arab Emirates: A report from Dubai. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Overweight http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32616491&form=6&db=m Incidence and risk factors of type 2 diabetes mellitus in an overweight and obese population: a long-term retrospective cohort study from a Gulf state. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 5.1.3.7 Papillomavirus Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24289628&form=6&db=m Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Papillomavirus Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29945637&form=6&db=m Frequency of rare and multi viral high-risk HPV types infection in cervical high grade squamous intraepithelial lesions in a non-native dominant middle eastern country: a polymerase chain reaction-based pilot study. therapeutic application,unassigned 2,0 5.1.3.7 Parasitic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21814832&form=6&db=m Applicability of molecular markers to determine parasitic infection origins in the animal trade: a case study from Sarcoptes mites in wildebeest. diagnostic usage,ongoing research,unassigned 3,2,0 5.1.3.7 Pediatric Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11755476&form=6&db=m Childhood and adolescent diabetes mellitus in Arabs residing in the United Arab Emirates. unassigned - 5.1.3.7 Pediatric Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788356&form=6&db=m Childhood obesity in United Arab Emirates schoolchildren: a national study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 5.1.3.7 Pediatric Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22890490&form=6&db=m The prevalence and potential determinants of obesity among school children and adolescents in Abu Dhabi, United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Pediatric Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30980621&form=6&db=m Content Analysis of Media Coverage of Childhood Obesity Topics in UAE Newspapers and Popular Social Media Platforms, 2014-2017. causal interaction,ongoing research,therapeutic application,unassigned 1,2,1,0 5.1.3.7 Periapical Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33378378&form=6&db=m Antibiotic prescribing practices of dentists for endodontic infections; a cross-sectional study. unassigned - 5.1.3.7 Periodontitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26496329&form=6&db=m Association of Periodontitis With Urinary Albumin Excretion in Korean Adults With Diabetes: The 2012 Korea National Health and Nutrition Examination Survey. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,2 5.1.3.7 Peripheral Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28107340&form=6&db=m Association of Diabetes Related Complications with Heart Rate Variability among a Diabetic Population in the UAE. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 5.1.3.7 Peripheral Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Peripheral Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9288546&form=6&db=m Increased prevalence of elevated urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Peripheral Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16015000&form=6&db=m Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Peritonitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26762798&form=6&db=m Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 5.1.3.7 Persistent Vegetative State http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29979643&form=6&db=m Provision of renal care for patients with end stage kidney disease in persistent vegetative state, in United Arab Emirates: a national survey of renal physicians. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Phytoplasma Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27757373&form=6&db=m Population genetic analysis reveals a low level of genetic diversity of 'Candidatus Phytoplasma aurantifolia' causing witches' broom disease in lime. unassigned - 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18501901&form=6&db=m Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19860229&form=6&db=m [Anesthesia by epidural anesthesia for five caesarian sections in patients with placenta previa percreta combined with placenta accreta] therapeutic application,unassigned 1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20227296&form=6&db=m Placenta accreta: management with uterine artery embolization in 17 cases. ongoing research,therapeutic application,unassigned 3,3,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20708528&form=6&db=m Placenta accreta following uterine artery embolization. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21463422&form=6&db=m Failure of uterine artery embolization for controlling postpartum hemorrhage. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21498276&form=6&db=m Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22622352&form=6&db=m Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. therapeutic application,unassigned 4,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23719249&form=6&db=m Placenta accreta in a patient with a history of uterine artery embolization for postpartum hemorrhage. ongoing research,unassigned 1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24670673&form=6&db=m UTERINE ARTERY EMBOLIZATION FOR UTERINE ARTERIOVENOUS MALFORMATION IS ASSOCIATED WITH PLACENTAL ABNORMALITIES IN THE SUBSEQUENT PREGNANCY: TWO CASES REPORT. diagnostic usage,therapeutic application,unassigned 2,4,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25937242&form=6&db=m Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. therapeutic application,unassigned 1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26382745&form=6&db=m Bleeding after dilatation and curettage: the efficacy of transcatheter uterine artery embolisation. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28050294&form=6&db=m Buttock Necrosis after Uterine Artery Embolization for Delayed Hysterectomy in Placenta Percreta. causal interaction,therapeutic application,unassigned 2,2,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28065219&form=6&db=m Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28098341&form=6&db=m Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. therapeutic application,unassigned 1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29736284&form=6&db=m A Case of Placenta Percreta Managed with Sequential Embolisation Procedures. diagnostic usage,therapeutic application,unassigned 3,2,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30511467&form=6&db=m Case of uterine rupture after multiple intrauterine operations and uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30701289&form=6&db=m Prophylactic Occlusion Balloon Placement in the Abdominal Aorta Combined with Uterine or Ovarian Artery Embolization for the Prevention of Cesarean Hysterectomy Due to Placenta Accreta: A Retrospective Study. therapeutic application,unassigned 1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30922797&form=6&db=m Uterine Artery Embolization following Cesarean Delivery but prior to Hysterectomy in the Management of Patients with Invasive Placenta. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31778209&form=6&db=m Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32184677&form=6&db=m Obstetric Outcomes of Pregnancy After Uterine Artery Embolization. diagnostic usage,unassigned 3,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32282925&form=6&db=m Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder-A comparative study. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32590166&form=6&db=m High-intensity focused ultrasound versus uterine artery embolization for patients with retained placenta accreta. causal interaction,therapeutic application,unassigned 2,2,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34413380&form=6&db=m A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34420286&form=6&db=m [Evaluation of the diagnosis and treatment of cesarean scar pregnancy induced in the second trimester: a national multicenter retrospective study]. causal interaction,diagnostic usage,unassigned 1,1,0 5.1.3.7 Placenta Accreta http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34545059&form=6&db=m The Efficacy and Postoperative Follow-Up of Different Interventional Methods in Cesarean Section for Placenta Accreta Spectrum Disorders. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24911560&form=6&db=m A clinical analysis of uterine artery embolisation in the treatment of placenta praevia or placenta praevia state. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25368788&form=6&db=m Anesthetic management of a parturient with placenta previa totalis undergoing preventive uterine artery embolization before placental expulsion during cesarean delivery: a case report. causal interaction,ongoing research,unassigned 3,1,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29714871&form=6&db=m Preliminary experience in uterine artery embolization for second trimester pregnancy induced labor with complete placenta previa, placenta implantation, and pernicious placenta previa. unassigned - 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29949293&form=6&db=m Successful management of complete placenta previa after intrauterine fetal death in a second-trimester pregnancy by uterine artery embolization: case report and literature review. causal interaction,therapeutic application,unassigned 3,2,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30076600&form=6&db=m Effects of prophylactic uterine artery embolization on second-trimester induced abortions in patients with placenta previa. diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31689838&form=6&db=m Prophylactic intraoperative uterine or internal iliac artery embolization in planned cesarean for pernicious placenta previa in the third trimester of pregnancy: An observational Study (STROBE compliant). unassigned - 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31778209&form=6&db=m Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32464719&form=6&db=m [Clinical investigation in the methods for complete placenta previa labor induction in the second trimester]. causal interaction,therapeutic application,unassigned 4,3,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34375912&form=6&db=m Clinical factors associated with a placenta accreta spectrum. diagnostic usage,therapeutic application,unassigned 1,3,0 5.1.3.7 Placenta Previa http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34413380&form=6&db=m A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Placenta, Retained http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28246515&form=6&db=m Efficacy of Prophylactic Uterine Artery Embolization before Obstetrical Procedures with High Risk for Massive Bleeding. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Placenta, Retained http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32590166&form=6&db=m High-intensity focused ultrasound versus uterine artery embolization for patients with retained placenta accreta. causal interaction,therapeutic application,unassigned 2,2,0 5.1.3.7 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16700188&form=6&db=m Demographics and microbiological profile of pneumonia in United Arab Emirates. ongoing research,unassigned 3,0 5.1.3.7 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34469441&form=6&db=m Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. causal interaction,unassigned 1,0 5.1.3.7 Polycystic Kidney, Autosomal Dominant http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11340355&form=6&db=m Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Polycystic Kidney, Autosomal Dominant http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20413443&form=6&db=m Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease. causal interaction,unassigned 4,0 5.1.3.7 Polycystic Kidney, Autosomal Dominant http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20888104&form=6&db=m Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. diagnostic usage,unassigned 4,0 5.1.3.7 Polyhydramnios http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34215203&form=6&db=m Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Polyneuropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23390836&form=6&db=m The metabolic syndrome is associated with high-normal urinary albumin excretion and retinopathy in normoalbuminuric type 1 diabetic patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15797303&form=6&db=m Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18501901&form=6&db=m Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,1,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20386442&form=6&db=m Impact of previous uterine artery embolization on fertility. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21498276&form=6&db=m Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23719249&form=6&db=m Placenta accreta in a patient with a history of uterine artery embolization for postpartum hemorrhage. ongoing research,unassigned 1,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23966814&form=6&db=m Pathological findings in a case of failed uterine artery embolization for placenta previa. unassigned - 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24639786&form=6&db=m Uterine artery embolization for primary postpartum hemorrhage. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25951726&form=6&db=m Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm. ongoing research,therapeutic application,unassigned 2,1,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27589544&form=6&db=m Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. causal interaction,unassigned 2,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28065219&form=6&db=m Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28098341&form=6&db=m Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. therapeutic application,unassigned 1,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28251148&form=6&db=m Emergent Uterine Arterial Embolization Using N-Butyl Cyanoacrylate in Postpartum Hemorrhage with Disseminated Intravascular Coagulation. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30663943&form=6&db=m Uterine artery embolization versus cesarean hysterectomy in the management of postpartum hemorrhage. causal interaction,therapeutic application,unassigned 3,3,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34413380&form=6&db=m A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Postpartum Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34420286&form=6&db=m [Evaluation of the diagnosis and treatment of cesarean scar pregnancy induced in the second trimester: a national multicenter retrospective study]. causal interaction,diagnostic usage,unassigned 1,1,0 5.1.3.7 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17825752&form=6&db=m Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. causal interaction,unassigned 2,0 5.1.3.7 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22415814&form=6&db=m Severe Acute Maternal Morbidity in a High-Income Developing Multiethnic Country. causal interaction,diagnostic usage,unassigned 4,1,0 5.1.3.7 Pre-Eclampsia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32568122&form=6&db=m A review of gestational diabetes mellitus management, risk factors, maternal and neonatal outcomes in two major maternity hospitals in the United Arab Emirates: A report from Dubai. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Prediabetic State http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31767874&form=6&db=m Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. causal interaction,diagnostic usage,unassigned 1,4,0 5.1.3.7 Pregnancy Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19023734&form=6&db=m Size at birth in a rapidly developing economy: intrauterine growth pattern of UAE infants. ongoing research,unassigned 3,0 5.1.3.7 Pregnancy Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23701904&form=6&db=m Uterine artery embolization and its effect on fertility. unassigned - 5.1.3.7 Pregnancy Complications http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28250724&form=6&db=m The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes - a review of literature. causal interaction,unassigned 4,0 5.1.3.7 Pregnancy, Abdominal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29657689&form=6&db=m Successful Management of Abdominal Pregnancy: Two Case Reports. diagnostic usage,unassigned 3,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18791728&form=6&db=m Uterine artery embolization as an adjunctive measure to decrease blood loss prior to evacuating a cervical pregnancy. causal interaction,unassigned 1,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19457824&form=6&db=m Uterine artery embolization along with the administration of methotrexate for cervical ectopic pregnancy: technical and clinical outcomes. causal interaction,ongoing research,therapeutic application,unassigned 2,3,3,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20382082&form=6&db=m Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolization. causal interaction,therapeutic application,unassigned 4,4,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23465260&form=6&db=m Intramural ectopic pregnancy: treatment using uterine artery embolization. causal interaction,therapeutic application,unassigned 2,3,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23945024&form=6&db=m Spontaneous uterine rupture at 32 weeks of gestation after previous uterine artery embolization. causal interaction,ongoing research,therapeutic application,unassigned 2,4,3,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28246515&form=6&db=m Efficacy of Prophylactic Uterine Artery Embolization before Obstetrical Procedures with High Risk for Massive Bleeding. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28462440&form=6&db=m Safety and Efficacy of Uterine Artery Embolization in Ectopic Pregnancies Refractory to Systemic Methotrexate Treatment: A Single-Center Study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,4,0 5.1.3.7 Pregnancy, Ectopic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31005344&form=6&db=m Uterine Artery Embolization and Methotrexate Infusion as Sole Management for Caesarean Scar and Cervical Ectopic Pregnancies: A Single-Center Experience and Literature Review. causal interaction,unassigned 2,0 5.1.3.7 Pregnancy, High-Risk http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22907793&form=6&db=m Pregnancy after uterine artery embolization for the treatment of myomas: a case series. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 5.1.3.7 Pregnancy, Interstitial http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20110090&form=6&db=m Combined use of uterine artery embolization and local methotrexate injection in interstitial ectopic pregnancies with poor prognosis. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,4,0 5.1.3.7 Pregnancy, Tubal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18193248&form=6&db=m Ectopic pregnancy after successful treatment with percutaneous transcatheter uterine arterial embolization for congenital uterine arteriovenous malformation: a case report. therapeutic application,unassigned 4,0 5.1.3.7 Premature Birth http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32184677&form=6&db=m Obstetric Outcomes of Pregnancy After Uterine Artery Embolization. diagnostic usage,unassigned 3,0 5.1.3.7 Premature Birth http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34413380&form=6&db=m A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 5.1.3.7 Primary Ovarian Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328788&form=6&db=m Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. causal interaction,unassigned 3,0 5.1.3.7 Primary Ovarian Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24505954&form=6&db=m [Uterine artery embolization--clinical problems]. therapeutic application,unassigned 1,0 5.1.3.7 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15190657&form=6&db=m Epidemiology of prostate cancer in United Arab Emirates. unassigned - 5.1.3.7 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25217421&form=6&db=m Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 5.1.3.7 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26723895&form=6&db=m Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP group. therapeutic application,unassigned 1,0 5.1.3.7 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28693428&form=6&db=m Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3535002&form=6&db=m Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8361875&form=6&db=m [Enalapril in patients with diabetes mellitus type I with microalbuminuria without hypertension] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8614290&form=6&db=m Serum type III, IV collagens and TIMP in patients with type II diabetes mellitus. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9886748&form=6&db=m Progression to overt proteinuria in microalbuminuric Koreans with non-insulin-dependent diabetes mellitus. diagnostic usage,therapeutic application,unassigned 3,1,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718833&form=6&db=m Increased urinary albumin excretion in Cushing's syndrome: remission after correction of hypercortisolaemia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11131271&form=6&db=m Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,4 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12145184&form=6&db=m Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,4,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16550747&form=6&db=m Microalbuminuria and deterioration of renal function after elective repair of infrarenal abdominal aortic aneurysm. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16871239&form=6&db=m Time to abandon microalbuminuria? unassigned - 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17217438&form=6&db=m Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. diagnostic usage,ongoing research,unassigned 3,2,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17949457&form=6&db=m Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients. ongoing research,therapeutic application,unassigned 3,1,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18299683&form=6&db=m Proteinuria: natural course, prognostic implications and therapeutic considerations. causal interaction,unassigned 3,0 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18346408&form=6&db=m [Prevalence and clinical characteristics of microalbuminuria in the Spanish hypertensive population.] unassigned - 5.1.3.7 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540895&form=6&db=m Pattern of acute glomerulonephritis in adult population in Dubai: A single-center experience. diagnostic usage,ongoing research,unassigned 2,4,0 5.1.3.7 Pseudotumor Cerebri http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16218911&form=6&db=m Idiopathic intracranial hypertension in Dubai: nature and prognosis. diagnostic usage,ongoing research,unassigned 4,2,0 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1523110&form=6&db=m Standardization of a device to measure unsupported arm exercise endurance in chronic obstructive pulmonary disease. therapeutic application,unassigned 4,0 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1535920&form=6&db=m Dyspnea-limited response in chronic obstructive pulmonary disease: reduced unsupported arm activities. therapeutic application,unassigned 2,0 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8503757&form=6&db=m Instrument development in the measurement of unsupported arm exercise endurance in normal adult subjects. therapeutic application,unassigned 4,0 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11770210&form=6&db=m Relationship between pulmonary function and unsupported arm exercise in patients with COPD. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,2 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23290701&form=6&db=m Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. diagnostic usage,ongoing research,unassigned 3,1,0 5.1.3.7 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33555228&form=6&db=m The effect of unsupported arm elevations on regional chest wall volumes and thoracoabdominal asynchrony in patients with chronic obstructive pulmonary disease. diagnostic usage,ongoing research,unassigned 2,2,0 5.1.3.7 Pulmonary Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29391803&form=6&db=m Acute pulmonary embolism in a patient with cesarean scar pregnancy after receiving uterine artery embolization: a case report. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Pulmonary Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30545548&form=6&db=m Repeated pulmonary embolism with cardiac arrest after uterine artery embolization for uterine arteriovenous malformation: A case report and literature review. therapeutic application,unassigned 3,0 5.1.3.7 Pulmonary Embolism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31409569&form=6&db=m Uterine Artery Embolization with Gelfoam for Acquired Symptomatic Uterine Arteriovenous Shunting. unassigned - 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8471229&form=6&db=m Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. causal interaction,ongoing research,therapeutic application,unassigned 1,4,4,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15461981&form=6&db=m Acute renal failure after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130259&form=6&db=m Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. causal interaction,unassigned 4,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17130268&form=6&db=m Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension. diagnostic usage,unassigned 3,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675621&form=6&db=m Safety and utility of uterine artery embolization with CO2 and a gadolinium-based contrast medium. therapeutic application,unassigned 4,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18573564&form=6&db=m Coronary artery calcification, arterial stiffness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients. causal interaction,unassigned 1,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21441399&form=6&db=m Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) Study. diagnostic usage,ongoing research,unassigned 1,3,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29979643&form=6&db=m Provision of renal care for patients with end stage kidney disease in persistent vegetative state, in United Arab Emirates: a national survey of renal physicians. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33520290&form=6&db=m Predictive Value of Creatinine-based Equations of Kidney Function in the Long-term Prognosis in United Arab Emirates Patients. causal interaction,diagnostic usage,unassigned 3,4,0 5.1.3.7 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16957423&form=6&db=m Influence of sympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretion. causal interaction,diagnostic usage,unassigned 1,2,0 5.1.3.7 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26241021&form=6&db=m Chronic kidney disease: ACR versus UAE. unassigned - 5.1.3.7 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27965374&form=6&db=m Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study. causal interaction,diagnostic usage,unassigned 2,4,0 5.1.3.7 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31615494&form=6&db=m Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 5.1.3.7 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34347565&form=6&db=m Association of Sleep Disordered Breathing and Blood Pressure with Albuminuria: The Nagahama Study. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Respiratory Distress Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22361573&form=6&db=m Early urinary aldosterone excretion in very low birth weight infants. causal interaction,diagnostic usage,unassigned 3,1,0 5.1.3.7 Respiratory Distress Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27424689&form=6&db=m Evaluation of aldosterone excretion in very low birth weight infants. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Respiratory Syncytial Virus Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9057448&form=6&db=m Respiratory syncytial virus infection among hospitalized young children with acute lower respiratory illnesses in Al Ain, UAE. causal interaction,diagnostic usage,unassigned 3,3,0 5.1.3.7 Respiratory Syncytial Virus Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31871513&form=6&db=m Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study. causal interaction,unassigned 4,0 5.1.3.7 Sarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17083970&form=6&db=m Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8902924&form=6&db=m The effect of epilepsy on road traffic accidents and casualties. unassigned - 5.1.3.7 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25233482&form=6&db=m Midwakh-induced seizures: case series from UAE. unassigned - 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12525461&form=6&db=m Incomplete vaginal expulsion of pyoadenomyoma with sepsis and focal bladder necrosis after uterine artery embolization for symptomatic adenomyosis: case report. diagnostic usage,therapeutic application,unassigned 3,2,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12817046&form=6&db=m Fatal sepsis after uterine artery embolization with microspheres. diagnostic usage,therapeutic application,unassigned 3,2,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17194302&form=6&db=m The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004. causal interaction,therapeutic application,unassigned 3,1,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328788&form=6&db=m Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. causal interaction,unassigned 3,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23470066&form=6&db=m Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24099448&form=6&db=m Fibroid Infected With Escherichia Coli Requiring Surgical Removal Following Uterine Artery Embolization. causal interaction,therapeutic application,unassigned 2,3,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28856930&form=6&db=m Sepsis after uterine artery embolization-assisted termination of pregnancy with complete placenta previa: A case report. causal interaction,unassigned 1,0 5.1.3.7 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33399491&form=6&db=m Sepsis following hysteroscopic myomectomy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,4,0 5.1.3.7 Severe Acute Respiratory Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34427922&form=6&db=m Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 5.1.3.7 Sickle Cell Trait http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16602448&form=6&db=m Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. diagnostic usage,unassigned 1,0 5.1.3.7 Sleep Apnea Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23516139&form=6&db=m Prevalence of symptoms and risk of sleep apnea in Dubai, UAE. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Sleep Apnea Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28070158&form=6&db=m Obesity and Sleep-Related Breathing Disorders in Middle East and UAE. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Sleep Apnea, Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18335264&form=6&db=m Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 5.1.3.7 Sleep Wake Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28070158&form=6&db=m Obesity and Sleep-Related Breathing Disorders in Middle East and UAE. causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Soft Tissue Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26124673&form=6&db=m Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates. ongoing research,therapeutic application,unassigned 1,3,0 5.1.3.7 Solitary Kidney http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3396223&form=6&db=m Microalbuminuria in single kidney patients: relationship with protein intake. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Spasm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17053762&form=6&db=m [Effect of technical and anatomical factors on efficacy of embolization of uterine arteries] causal interaction,therapeutic application,unassigned 1,1,0 5.1.3.7 Spondylitis, Ankylosing http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9542780&form=6&db=m The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 ST Elevation Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26734321&form=6&db=m Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction In Primary Percutaneous Intervention: Transformation using Robust Performance Improvement. causal interaction,diagnostic usage,unassigned 3,2,0 5.1.3.7 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21751147&form=6&db=m Sequential alterations in gastric biopsies and tumor tissues support the multistep process of carcinogenesis. causal interaction,therapeutic application,unassigned 4,1,0 5.1.3.7 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33051794&form=6&db=m Epidemiology of Gastric Cancer in North Africa and the Middle East from 1990 to 2017. unassigned - 5.1.3.7 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34048197&form=6&db=m Knowledge, Attitudes and Practices of Adults in the United Arab Emirates Regarding Helicobacter pylori induced Gastric Ulcers and Cancers. diagnostic usage,unassigned 1,0 5.1.3.7 Stomach Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34048197&form=6&db=m Knowledge, Attitudes and Practices of Adults in the United Arab Emirates Regarding Helicobacter pylori induced Gastric Ulcers and Cancers. diagnostic usage,unassigned 1,0 5.1.3.7 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8908388&form=6&db=m Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10546024&form=6&db=m Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. diagnostic usage,unassigned 4,0 5.1.3.7 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12882845&form=6&db=m Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. diagnostic usage,unassigned 3,0 5.1.3.7 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20733300&form=6&db=m Level of albuminuria and risk of stroke: systematic review and meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 5.1.3.7 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31983291&form=6&db=m Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 5.1.3.7 Syphilis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8915734&form=6&db=m Serologic tests for treponematoses in the United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Takayasu Arteritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30835520&form=6&db=m Uterine Artery Embolization in Patients With Autoimmune Disease: A Matched Case-Control Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 5.1.3.7 Temporomandibular Joint Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29861731&form=6&db=m Prevalence of TMJ Disorders among the Patients Attending the Dental Clinic of Ajman University of Science and Technology-Fujairah Campus, UAE. unassigned - 5.1.3.7 Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20437613&form=6&db=m Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). diagnostic usage,therapeutic application,unassigned 2,2,0 5.1.3.7 Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22281991&form=6&db=m Serum ferritin levels and endocrinopathy in medically treated patients with ? thalassemia major. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,1,0 5.1.3.7 Thalassemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23606864&form=6&db=m Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. unassigned - 5.1.3.7 Thrombophilia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14514806&form=6&db=m Changes in blood coagulation markers associated with uterine artery embolization for leiomyomata. causal interaction,diagnostic usage,unassigned 4,1,0 5.1.3.7 Thyroid Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20063523&form=6&db=m Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital. diagnostic usage,ongoing research,unassigned 1,2,0 5.1.3.7 Thyroid Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30519286&form=6&db=m Thyroid malignancy among patients with thyroid nodules in the United Arab Emirates: a five-year retrospective tertiary Centre analysis. causal interaction,unassigned 3,0 5.1.3.7 Thyroid Nodule http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30519286&form=6&db=m Thyroid malignancy among patients with thyroid nodules in the United Arab Emirates: a five-year retrospective tertiary Centre analysis. causal interaction,unassigned 3,0 5.1.3.7 Thyroid Nodule http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33826647&form=6&db=m Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison. unassigned - 5.1.3.7 Tick-Borne Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34451469&form=6&db=m Four Tick-Borne Microorganisms and Their Prevalence in Hyalomma Ticks Collected from Livestock in United Arab Emirates. causal interaction,unassigned 2,0 5.1.3.7 Tonsillitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24676179&form=6&db=m Patterns of Antimicrobial therapy in acute tonsillitis: A cross-sectional Hospital-based study from UAE. ongoing research,therapeutic application,unassigned 3,3,0 5.1.3.7 Tooth Avulsion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29062362&form=6&db=m Assessment of Elementary School Teachers' Level of Knowledge and Attitude regarding Traumatic Dental Injuries in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 Toxoplasmosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12062794&form=6&db=m Serological evidence for remarkably variable prevalence rates of Toxoplasma gondii in children of major residential areas in United Arab Emirates. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 5.1.3.7 Toxoplasmosis, Congenital http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20570441&form=6&db=m Toxoplasmosis in Sand cats (Felis margarita) and other animals in the Breeding Centre for Endangered Arabian Wildlife in the United Arab Emirates and Al Wabra Wildlife Preservation, the State of Qatar. therapeutic application,unassigned 1,0 5.1.3.7 Treponemal Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8915734&form=6&db=m Serologic tests for treponematoses in the United Arab Emirates. causal interaction,unassigned 3,0 5.1.3.7 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15608476&form=6&db=m Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 5.1.3.7 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20461130&form=6&db=m Susceptibility Pattern and Epidemiology of Mycobacterium tuberculosis in United Emirati Hospital. causal interaction,ongoing research,therapeutic application,unassigned 3,2,4,0 5.1.3.7 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28403215&form=6&db=m Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities. ongoing research,unassigned 3,0 5.1.3.7 Urinary Tract Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34215203&form=6&db=m Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE. causal interaction,therapeutic application,unassigned 2,1,0 5.1.3.7 Usher Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24194196&form=6&db=m Analysis of two Arab families reveals additional support for a DFNB2 nonsyndromic phenotype of MYO7A. unassigned - 5.1.3.7 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24289628&form=6&db=m Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. diagnostic usage,ongoing research,unassigned 3,3,0 5.1.3.7 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26610743&form=6&db=m Correlation of cervical cytology with high-risk HPV molecular diagnosis, genotypes, and histopathology-A four year study from the UAE. unassigned - 5.1.3.7 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27622185&form=6&db=m A Content Analysis of Arabic and English Newspapers before, during, and after the Human Papillomavirus Vaccination Campaign in the United Arab Emirates. therapeutic application,unassigned 1,0 5.1.3.7 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29286607&form=6&db=m Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates causal interaction,unassigned 1,0 5.1.3.7 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30718317&form=6&db=m A report on the Marrakech International Women's Cancer Days: dialogs and implications. unassigned - 5.1.3.7 Uterine Cervicitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16287010&form=6&db=m Improving quality of care for patients undergoing arterial embolization for uterine fibroids: case report and review. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10868607&form=6&db=m Uterine artery embolization: a minimally invasive technique for the treatment of uterine fibroids. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12816692&form=6&db=m [Clinical analysis of lower uterine segment pregnancy with heavy hemorrhage in inducing abortion] ongoing research,unassigned 1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12875683&form=6&db=m Lower uterine segment pregnancy with placenta increta complicating first trimester induced abortion: diagnosis and conservative management. therapeutic application,unassigned 1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15656217&form=6&db=m Successful management of cervical pregnancy by selective uterine artery embolization: a case report. therapeutic application,unassigned 1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17694980&form=6&db=m Endometrial ablation in a woman with a persistent uterine hemorrhage due to acute promyelocytic leukemia: a case report. causal interaction,therapeutic application,unassigned 2,4,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18430385&form=6&db=m Septic uterus after uterine artery embolization for uterine myomas triggered by endometrial biopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19457824&form=6&db=m Uterine artery embolization along with the administration of methotrexate for cervical ectopic pregnancy: technical and clinical outcomes. causal interaction,ongoing research,therapeutic application,unassigned 2,3,3,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19560937&form=6&db=m Importance of angiographic visualization of round ligament arteries in women evaluated for intractable vaginal bleeding after uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20400332&form=6&db=m Transcatheter Intraarterial Methotrexate Infusion Combined with Selective Uterine Artery Embolization as a Treatment Option for Cervical Pregnancy. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20889136&form=6&db=m An efficient conservative treatment modality for cervical pregnancy: angiographic uterine artery embolization followed by immediate curettage. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22115582&form=6&db=m Postpartum hemorrhage in coagulopathic patients: preliminary experience with uterine arterial embolization with N-butyl cyanoacrylate. causal interaction,diagnostic usage,unassigned 1,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25951726&form=6&db=m Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm. ongoing research,therapeutic application,unassigned 2,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26382745&form=6&db=m Bleeding after dilatation and curettage: the efficacy of transcatheter uterine artery embolisation. diagnostic usage,therapeutic application,unassigned 1,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26525692&form=6&db=m Uterine artery embolization combined with intra-arterial MTX infusion: its application in treatment of cervical pregnancy. diagnostic usage,unassigned 1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26644262&form=6&db=m A comparison of high-intensity focused ultrasound and uterine artery embolisation for the management of caesarean scar pregnancy. diagnostic usage,therapeutic application,unassigned 2,1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27627607&form=6&db=m Successful conservative treatment of cervical pregnancy with uterine artery embolization followed by curettage: a report of 19 cases. ongoing research,unassigned 1,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28065219&form=6&db=m Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta. diagnostic usage,therapeutic application,unassigned 3,4,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28246515&form=6&db=m Efficacy of Prophylactic Uterine Artery Embolization before Obstetrical Procedures with High Risk for Massive Bleeding. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28462440&form=6&db=m Safety and Efficacy of Uterine Artery Embolization in Ectopic Pregnancies Refractory to Systemic Methotrexate Treatment: A Single-Center Study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,4,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28746234&form=6&db=m Outcome of high-intensity focused ultrasound and uterine artery embolization in the treatment and management of cesarean scar pregnancy: A retrospective study. unassigned - 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29777846&form=6&db=m An Academic Tertiary Referral Center's Experience with a Vascular Surgery-Based Uterine Artery Embolization Program. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,2,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29854485&form=6&db=m Successful Management of Cervical Ectopic Pregnancy with Bilateral Uterine Artery Embolization and Methotrexate. ongoing research,therapeutic application,unassigned 1,2,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31005344&form=6&db=m Uterine Artery Embolization and Methotrexate Infusion as Sole Management for Caesarean Scar and Cervical Ectopic Pregnancies: A Single-Center Experience and Literature Review. causal interaction,unassigned 2,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32672434&form=6&db=m Efficacy of different treatment of 134 cases of cesarean scar pregnancy. therapeutic application,unassigned 3,0 5.1.3.7 Uterine Hemorrhage http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34258277&form=6&db=m Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia. therapeutic application,unassigned 3,0 5.1.3.7 Uterine Inertia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21463422&form=6&db=m Failure of uterine artery embolization for controlling postpartum hemorrhage. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 5.1.3.7 Uterine Inertia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29641227&form=6&db=m Primary postpartum hemorrhage: outcome of uterine artery embolization. unassigned - 5.1.3.7 Uterine Inertia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32662700&form=6&db=m Postpartum hemorrhage with uterine artery embolization: the risk of complications of uterine artery embolization. therapeutic application,unassigned 1,0 5.1.3.7 Uterine Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33115685&form=6&db=m Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,2 5.1.3.7 Uterine Rupture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11960052&form=6&db=m Ischemic uterine rupture and hysterectomy 3 months after uterine artery embolization. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Uterine Rupture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18653292&form=6&db=m [Pregnancy after uterine-artery embolization for symptomatic fibroids: a case of placenta accreta with uterine rupture] therapeutic application,unassigned 1,0 5.1.3.7 Uterine Rupture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23945024&form=6&db=m Spontaneous uterine rupture at 32 weeks of gestation after previous uterine artery embolization. causal interaction,ongoing research,therapeutic application,unassigned 2,4,3,0 5.1.3.7 Uterine Rupture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30511467&form=6&db=m Case of uterine rupture after multiple intrauterine operations and uterine artery embolization. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 5.1.3.7 Vaginal Discharge http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16437515&form=6&db=m Uterine artery embolization for symptomatic uterine fibroids. causal interaction,therapeutic application,unassigned 3,4,0 5.1.3.7 Vaginal Discharge http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328788&form=6&db=m Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. causal interaction,unassigned 3,0 5.1.3.7 Vaginal Discharge http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28807810&form=6&db=m Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,3,0 5.1.3.7 Vaginal Discharge http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29998027&form=6&db=m Uterine Necrosis after Uterine Artery Embolization for Symptomatic Fibroids. causal interaction,therapeutic application,unassigned 1,2,0 5.1.3.7 Vaginal Discharge http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34012498&form=6&db=m Microspheres vaginal discharge as a complication after Uterine Artery Embolization for intramural/submucosal fibroid. causal interaction,unassigned 2,0 5.1.3.7 Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29777846&form=6&db=m An Academic Tertiary Referral Center's Experience with a Vascular Surgery-Based Uterine Artery Embolization Program. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,2,0 5.1.3.7 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9057448&form=6&db=m Respiratory syncytial virus infection among hospitalized young children with acute lower respiratory illnesses in Al Ain, UAE. causal interaction,diagnostic usage,unassigned 3,3,0 5.1.3.7 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22691239&form=6&db=m Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,2,0 5.1.3.7 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31871513&form=6&db=m Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study. causal interaction,unassigned 4,0 5.1.3.7 Vision Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33759709&form=6&db=m Association between visual impairment and sleep duration in college students: A study conducted in UAE and Lebanon. ongoing research,unassigned 1,0 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24261616&form=6&db=m Rheumatoid arthritis disease activity and vitamin D deficiency in an Asian resident population. causal interaction,ongoing research,unassigned 2,3,0 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27026018&form=6&db=m Vitamin D deficiency: knowledge and practices among the adult population in Sharjah, United Arab Emirates. ongoing research,unassigned 2,0 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27144152&form=6&db=m Assessment of prevalence of hypovitaminosis D in multiethnic population of the United Arab Emirates. unassigned - 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27693095&form=6&db=m Clinical practice guidelines for vitamin D in the United Arab Emirates. causal interaction,unassigned 2,0 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29657665&form=6&db=m Environmental determinants of previtamin D synthesis in the United Arab Emirates. unassigned - 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29664734&form=6&db=m Potential causes of asthma in the United Arab Emirates: drawing insights from the Arabian Gulf. causal interaction,ongoing research,unassigned 2,3,0 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31758340&form=6&db=m The sunshine under our skin: public knowledge and practices about vitamin D deficiency in Al Ain, United Arab Emirates. unassigned - 5.1.3.7 Vitamin D Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32663174&form=6&db=m Autism spectrum disorder in the United Arab Emirates: potential environmental links. causal interaction,unassigned 3,0 5.1.3.7 Vitiligo http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9479431&form=6&db=m Clinical and immunological studies in vitiligo in the United Arab Emirates. causal interaction,unassigned 2,0 5.1.3.7 Vitiligo http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15918298&form=6&db=m Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE. diagnostic usage,ongoing research,unassigned 4,3,0 5.1.3.7 Whooping Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31493522&form=6&db=m Pertussis Seronegativity in Pregnant Women in the City of Al Ain, United Arab Emirates. diagnostic usage,therapeutic application,unassigned 2,1,0